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Summary 
Telomeres are specialized nucleoprotein complexes found at the end of linear 
eukaryotic chromosomes required for genome integrity (Smogorzewska and de Lange, 
2004). Mammalian telomeric DNA is composed of tandem TTAGGG repeats bound by a 
series of associated proteins which are required for the protection and maintenance of 
telomeres from being recognized as double-strand DNA breaks (de Lange, 2002; Griffith 
et al., 1999). Most human normal somatic cells show a progressive loss of telomeric DNA 
during successive rounds of cell division due to a DNA end-replication problem (Cerone 
et al., 2005). Telomere homeostasis is regulated by telomerase and the six-subunit protein 
complex named shelterin, which consists of TRF1, TRF2, POT1, TIN2, TPP1, and Rap1 
(Chong et al., 1995; Liu et al., 2004). The shelterin complex plays an essential role in 
maintaining the integrity of telomere length and structure.  
Because the enzymatic activity of telomerase correlates with hTERT expression, 
hTERT is believed to be a key component of the telomerase holoenzyme. Several proteins 
have been identified to be involved in nuclear transport of hTERT. The molecular 
chaperones Hsp90 and p23 have been shown to interact with hTERT (Forsythe et al., 
2001; Holt et al., 1999), and these interactions are required to maintain hTERT in a 
conformation enabling nuclear translocation. Although the nuclear localization of hTERT 
is an important step in telomerase assembly, the precise molecular mechanism underlying 
nuclear transport of hTERT remains unresolved. In the first chapter, we demonstrate that 
FKBP52-dependent linkage between hTERT-Hsp90 and dynein motor is required for 
efficient nuclear transport of hTERT. Our finding provides a new route for modulating 
telomerase activity by regulating its nuclear import efficiency in human cancer cells. 
Among the shelterin subunits, TRF1 negatively regulates the telomere length by 
restricting telomerase access to the telomeres. The overexpression of TRF1 promotes 
telomere shortening, whereas the loss of TRF1 from the telomeres has been shown to 
induce abnormal telomere elongation (Smogorzewska et al., 2000; van Steensel and de 
Lange, 1997), suggesting that an abundance of TRF1 at the telomeres should be tightly 
controlled for maintaining telomere length. Therefore, the cellular level of TRF1 at the 
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telomeres has been shown to be tightly regulated. TRF1 is subject to extensive post-
translational modification (Walker and Zhu, 2012) and it is evident that the abundance of 
TRF1 has been shown to be regulated through interactions with various proteins. Recent  
studies have revealed the existence of numerous modifying enzymes, such as tankyrase 1, 
Fbx4, RLIM, CK2, Pin1, and Plk1, which contribute to the regulation of stability, binding 
activity, and localization of TRF1 (Walker and Zhu, 2012). 
In the second chapter, we describe a novel function of NUB1 for regulating the 
abundance of TRF1 in mammalian cells. We identified NEDD8 ultimate buster-1 (NUB1) 
as a negative regulator of TRF1 by directly interacting with TRF1. The overexpression of 
NUB1 significantly decreased the levels of TRF1 and also reduced the half-life of TRF1, 
whereas the depletion of NUB1 by the RNA interference stabilized the endogenous TRF1. 
These findings demonstrate that NUB1 plays a critical role in regulating the level of 
TRF1 at the telomeres. We also identified the novel post-translational modification of 
TRF1 (i.e., neddylation). We found for the first time that TRF1 is a target for NEDD8-
conjugation in vitro and in vivo and the treatment of MLN4924, which is an NAE 
inhibitor, efficiently reduces the neddylation of TRF1. We also identified that NEDP1, 
which is NEDD8-specific protease, directly interacts with TRF1 in vitro and clearly 
abolished the neddylation of TRF1 in vitro and in vivo. The present findings suggest that 
novel post-translational modification of TRF1, called neddylation for controlling the 
stability and subcellular localization, provides a potential mechanism for telomere 
maintenance. 
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Chapter I 
 
Hsp90 binding immunophilin FKBP52 
modulates telomerase activity by 
promoting nuclear transport of hTERT 
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1. Abstract 
 
Telomerase is a unique ribonucleoprotein enzyme that is required for continued cell 
proliferation. To generate catalytically active telomerase, hTERT should be 
transported to the nucleus and assembled with the telomerase RNA component. The 
molecular chaperones Hsp90 and p23 have been shown to maintain hTERT in a 
conformation enabling nuclear translocation. However, the regulatory role of 
chaperones in nuclear transport of hTERT remains unclear. In this work, we 
demonstrate that immunophilin FKBP52 links the hTERT-Hsp90 complex to 
dynein/dynactin motor, thereby promoting the cytoplasmic transport of hTERT to 
the nucleus along microtubule tracks. FKBP52 interacts with the hTERT-Hsp90 
complex through the TPR domain binding to Hsp90 as well as with the dynamitin 
component of the dynein-associated dynactin complex through the PPIase domain. 
Depletion of FKBP52 inhibits nuclear transport of hTERT and results in a 
cytoplasmic accumulation. The resulting cytoplasmic hTERT is rapidly degraded 
through ubiquitin-dependent proteolysis, thereby abrogating telomerase activity. In 
addition, overexpression of dynamitin, which is known to dissociate dynein/dynactin 
motor from its cargoes, reduced telomerase activity. These results provide a 
molecular mechanism by which FKBP52 modulates telomerase activity by 
regulating nuclear transport of hTERT. 
                                                                         
Keywords: Telomerase, hTERT, Nuclear transport, FKBP52, Hsp90, Dynein/dynactin 
motor 
 
 
 
 
 
 
３ 
 
2. Introduction 
 
Telomeres, the specialized nucleoprotein complexes found at the ends of linear 
chromosomes, are essential for chromosome integrity [1,2]. Properly capped telomeres 
protect chromosome termini from being recognized as DNA damage sites [3]. The 
maintenance of functional telomeres requires telomerase, a unique ribonucleoprotein 
enzyme that contains the telomerase reverse transcriptase (TERT), the telomerase RNA 
component (TERC) and several additional proteins for assembly and activity [4,5]. 
Telomerase adds telomere repeats to the chromosome ends by reverse transcription. In 
humans, telomerase activity is up-regulated in a majority of cancer cells but repressed in 
most normal somatic cells, indicating that activation of telomerase is required for tumor 
growth and survival [6].  
Because the enzymatic activity of telomerase correlates with hTERT expression, hTERT 
is believed to be a key component of the telomerase holoenzyme [7,8]. To generate 
catalytically active telomerase, hTERT should enter the nucleus through the nuclear pore 
complex (NPC) [9]. Several proteins have been identified to be involved in nuclear 
transport of hTERT. The molecular chaperones Hsp90 and p23 have been shown to 
interact with hTERT, and these interactions are required to maintain hTERT in a 
conformation enabling nuclear translocation [10,11]. On the other hand, binding of CHIP 
and Hsp70 to hTERT causes dissociation of p23 from hTERT, resulting in a failure of 
nuclear import. The resulting cytoplasmic hTERT is ubiquitinated by CHIP and 
subsequently degraded by the proteasome [12]. Importantly, the association of hTERT 
with CHIP appears to be cell cycle-dependent. CHIP-mediated hTERT degradation is not 
activated in S phase during which telomerase acts on telomeres [12]. Although the 
nuclear localization of hTERT is an important step in telomerase assembly, the precise 
molecular mechanism underlying nuclear transport of hTERT remains unresolved.  
Steroid hormone receptors (SHRs) and some other transcription factors have been shown 
to interact with Hsp90 in the cytoplasm [13]. The association of FKBP52 with cargo-
Hsp90 heterocomplexes is required for their nuclear transport [14]. FKBP52 consists of a 
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N-terminal FK1 domain that contains peptidyl prolyl isomerase (PPIase) activity, a 
middle FK2 domain that is structurally similar to FK1 but lacks PPIase activity and a C-
terminal tetratricopeptide repeat (TPR) domain that confers Hsp90 binding ability [15]. 
FKBP52 has also been shown to co-immunoprecipitate the dynein-dynactin complex, 
suggesting that the motor proteins are involved in nuclear transport of the Hsp90-binding 
cargo proteins [16-18]. Because Hsp90 binding to hTERT is essential for its nuclear 
import as well as assembly of the telomerase holoenzyme [10,11], we hypothesized that 
FKBP52 could play a potential role in nuclear transport of hTERT in a fashion similar to 
SHRs and other transcription factors.  
In this work, we analyzed whether FKBP52 modulates nuclear-cytoplasmic shuttling of 
hTERT. We demonstrate that FKBP52 associates with the hTERT-Hsp90 complex 
through the TPR domain, which is responsible for Hsp90 binding. FKBP52 also links this 
complex to cytoplasmic dynein motor through the interaction with dynamitin via the 
PPIase domain. Depletion of FKBP52 inhibits nuclear transport of hTERT and results in a 
cytoplasmic accumulation, thereby abrogating telomerase activity. In addition, 
overexpression of dynamitin, which is known to dissociate dynein motor from its cargoes 
[18], impairs nuclear localization of hTERT. These results suggest that FKBP52-
dependent linkage between hTERT-Hsp90 and dynein motor is required for efficient 
nuclear transport of hTERT. 
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3. Materials and Methods 
 
3.1 Yeast two hybrid screening 
Yeast two-hybrid screening was performed as described [19]. Briefly, the yeast strain 
EGY48 harboring pLexA-hTERT (amino acids 946–1132) and pSH18-34 was 
transformed by the lithium acetate method with a HeLa cDNA library fused to the 
activation domain vector pB42AD (Clontech). 
 
3.2 Cell culture and plasmids 
The human lung carcinoma cell line H1299 was cultured in RPMI 1640 medium 
supplemented with 10% fetal bovine serum, 100 units/ml penicillin, and 100μg/ml 
streptomycin in 5% CO2 at 37°C. The expression vectors for Myc-FKBP52, Myc-
FKBP51 and Myc-dynamitin were constructed by inserting the full-length cDNAs into 
pRK5-Myc (Stratagene). The GST-FKBP52 expression vector was constructed by 
inserting the full-length cDNA into pGEX-4T-2, and the GST fusion proteins were 
purified according to the manufacturer's instructions (Amersham Biosciences). The Flag-
hTERT expression vector has been described previously [20]. 
 
3.3 GST pulldown, immunoprecipitation and immunoblotting 
The expression vectors were transfected into cells using Lipofectamine 2000 (Invitrogen, 
Carlsbad, CA) for 24 h followed by lysis. GST pulldown, immunoprecipitation and 
immunoblotting were performed as described previously [19]. Immunoprecipitation and 
immunoblotting were performed using anti-Flag (Sigma, St. Louis, MO), anti-Myc (Santa 
Cruz Biotechnology, Santa Cruz, CA), anti-hTERT (ROCKLAND), anti-Hsp56 (Santa 
Cruz Biotechnology, Santa Cruz, CA), anti-FKBP51 (Santa Cruz Biotechnology, Santa 
Cruz, CA), anti-Hsp90 (Santa Cruz Biotechnology, Santa Cruz, CA), anti-Dynein IC 
(Santa Cruz Biotechnology, Santa Cruz, CA), and anti-tubulin (Santa Cruz Biotechnology, 
Santa Cruz, CA) antibodies as specified. All the immunoblots are representatives of at 
least three experiments that demonstrated the similar results. 
６ 
 
3.4 RNA interference 
The siRNA duplexes were transfected into H1299 cells using RNAiMax transfection 
reagent (Invitrogen, Carlsbad, CA). The siRNA target sequences specific for FKBP52 
were 5’-AAGTTCCATGCTTGAGCAATA-3’ for siFKBP52-1 and 5’-
AACTGTAACAAGGCCCTAGA A-3’ for siFKBP52-2. The siRNA target sequences 
specific for FKBP51 was 5’-ACCTAATGCTGAGCTTATA-3’. The control siRNA 
sequence (5’-AATTCTCCGAACGTGT CACGT-3’) was used as a control (Qiagen) and 
did not correspond to any known gene in the data bases. 
 
3.5 Immunofluorescence and confocal microscopy 
H1299 cells grown on glass coverslips were fixed with 4% paraformaldehyde in 
phosphate-buffered saline (PBS) for 10 min and permeabilized with 0.2% Triton X-100 in 
PBS for 15 min at room temperature. Cells were then blocked in PBS containing 5% 
bovine serum albumin. DNA was stained with 4,6-diamino-2-phenylindole (DAPI) 
(Vectashield; Vector Laboratories, Burlingame, CA). The subcellular distribution of GFP-
hTERT was monitored by confocal microscopy using a confocal laser-scanning 
microscope (LSM-700 Image, Carl Zeiss, Jena, Germany). Images were analyzed using 
the LSM-700 software. 
 
3.6 Telomerase assay  
The telomeric repeat amplification protocol (TRAP) was used as previously described 
[21]. 
 
3.7 In vivo ubiquitination assay 
H1299 cells were co-transfected with Flag-hTERT and HA-ubiquitin and treated with 10 
µM MG132 to inhibit proteasome function. Lysates were subjected to 
immunoprecipitation with anti-Flag M2 affinity resins (Sigma), followed by 
immunoblotting with anti-HA antibody to illuminate ubiquitin-conjugated hTERT. 
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4. Results 
 
4.1 FKBP52 affects the nuclear localization of hTERT and telomerase activity 
Hsp90-binding immunophilin FKBP52 has been shown to form complexes with steroid 
hormone receptors and some other transcription factors such as p53 and NF-κB and act as 
a positive regulator in their nuclear localization [14,22,23]. To extend this idea to other 
nuclear factors that undergo nuclear-cytoplasmic shuttling, we analyzed whether FKBP52 
modulates the nuclear translocation of hTERT. The expression of endogenous FKBP52 
was depleted using two different small interfering RNA (siRNA) duplexes (Fig. 1A). 
H1299 cells expressing GFP-hTERT were subjected to indirect immunofluorescence 
staining to monitor the subcellular localization of hTERT. Representative fluorescence 
images of GFP-hTERT are shown in Fig. 1B. Whereas GFP-hTERT was predominantly 
localized to the nucleus in the control siRNA cells, depletion of FKBP52 led to a 
significant decrease in total GFP-hTERT fluorescence intensity (Fig. 1B). However, the 
MG132 treatment rescued FKBP52 depletion-dependent reduction in GFP-hTERT 
fluorescence and resulted in a cytoplasmic accumulation of GFP-hTERT (Fig. 1B and C). 
These results suggest that, when FKBP52 was depleted, hTERT fails to enter the nucleus 
and is subsequently degraded by the proteasome. We next determined the effect of 
FKBP52 depletion on telomerase activity. Depletion of FKBP52 resulted in a significant 
reduction in telomerase activity compared to the control siRNA cells (Fig. 1D). To 
examine whether reduction in telomerase activity is due to a FKBP52 depletion-related 
decrease in the transcription levels of hTERT and TERC, the effect of FKBP52 depletion 
on gene expression of hTERT and TERC was evaluated using reverse transcription-PCR 
analysis. No significant difference was observed in the steady-state levels of hTERT 
mRNA and TERC transcript between FKBP52 knockdown cells and the control cells (Fig. 
1E). 
Because FKBP51 has been shown to function as a negative regulator of steroid hormone 
receptor activity [15], we examined whether depletion of FKBP51 influences the nuclear 
localization of hTERT. The expression of endogenous FKBP51 was depleted using 
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siRNA duplex (Fig. 2A). Whereas depletion of FKBP52 inhibits the nuclear translocation 
of hTERT, the majority of GFP-hTERT signal was detected in the nucleus even when 
FKBP51 was depleted (Fig. 2B and C). Depletion of endogenous p23, which inhibits 
nuclear localization of hTERT, was used as a control [12]. We further characterized the 
effect of FKBP51 depletion on telomerase activity and found that telomerase activity was 
not affected by FKBP51 depletion (Fig. 2D). Taken together, these results demonstrate 
that FKBP52, but not FKBP51, is required for nuclear localization of hTERT and 
telomerase activity. 
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Figure 1. Depletion of FKBP52 inhibits nuclear transport of hTERT and reduces 
telomerase activity. A) H1299 cells were transfected with control siRNA (siControl) or 
FKBP52 siRNAs (siFKBP52-1 and siFKBP52-2). The protein level of endogenous 
FKBP52 was measured by immunoblotting as indicated. B) H1299 cells transfected with 
GFP-hTERT and FKBP52 siRNAs were treated with or without 10 μM MG132 for 2 hr 
and subjected to immunofluorescence staining to monitor the subcellular localization of 
GFP-hTERT. The nuclei were stained with 4,6-diamidino-2-phenylindole (DAPI, blue). C) 
After transfection, H1299 cells were treated with 10 μM MG132 for 2 hr and subjected to 
quantitative analysis of the location of GFP-hTERT within the cells. In each experiment, 
more than 100 GFP-hTERT-expressing cells were evaluated quantitatively for nuclear (N, 
blue bars), nuclear-cytoplasmic (N+C, red bars), and cytoplasmic (C, green bars) 
fluorescence. D) H1299 cells transfected with control siRNA or FKBP52 siRNAs were 
analyzed for telomerase activity by the TRAP assay. To test RNA-dependent extension, 
RNase A (0.25 mg/ml) was added to the extracts before the primer extension reaction. 
ITAS represents the internal telomerase assay standard. E) H1299 cells transfected with 
control siRNA or FKBP52 siRNAs were subjected to reverse transcription-PCR analysis 
for the expression of hTERT and TERC genes. 
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Figure. 2. Depletion of FKBP51 does not affect the nuclear localization of hTERT 
and telomerase activity. A) H1299 cells were transfected with FKBP51 siRNA or 
siFKBP52 siRNA. The protein levels of endogenous FKBP51 and FKBP52 were 
measured by immunoblotting as indicated. B) H1299 cells transfected with GFP-hTERT 
and p23 siRNA or FKBP51 siRNA or FKBP52 siRNA were subjected to 
immunofluorescence staining to monitor the subcellular localization of GFP-hTERT. The 
nuclei were stained with 4,6-diamidino-2-phenylindole (DAPI, blue). C) After 
transfection, H1299 cells were subjected to quantitative analysis of the location of GFP-
hTERT within the cells. In each experiment, more than 100 GFP-hTERT-expressing cells 
were evaluated quantitatively for nuclear (N, blue bars), nuclear-cytoplasmic (N+C, red 
bars), and cytoplasmic (C, green bars) fluorescence. D) H1299 cells transfected with 
FKBP51 siRNA or FKBP52 siRNA were analyzed for telomerase activity by the TRAP 
assay. To test RNA-dependent extension, RNase A (0.25 mg/ml) was added to the 
extracts before the primer extension reaction. ITAS represents the internal telomerase 
assay standard. 
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4.2 FKBP52 associates with hTERT 
To investigate the molecular mechanism in which FKBP52 affects the nuclear 
localization of hTERT, we examined the association between hTERT and FKBP52 by the 
GST pulldown assay. GST-FKBP52, but not the control GST, precipitated Flag-hTERT 
expressed in H1299 cells, indicating that hTERT associates with FKBP52 in vitro (Fig. 
3A). To determine whether hTERT and FKBP52 associate in vivo, H1299 cells were co-
transfected with Flag-hTERT and Myc-FKBP52 expression vectors and subjected to 
immunoprecipitation. Myc-FKBP52 was detected in anti-Flag immunoprecipitates when 
Flag-hTERT was expressed (Fig. 3B). Likewise, Flag-hTERT was recovered in anti-Myc 
immunopecipitates when Myc-FKBP52 was expressed, indicating that hTERT associates 
with FKBP52 in mammalian cells.  
Because the molecular chaperones Hsp90 and p23 have been shown to associate with 
hTERT for the assembly of active telomerase [10,11], we performed the GST pulldown 
assay to determine whether the hTERT-FKBP52 complex contains molecular chaperones. 
As shown in Fig. 3C, the pulldown of GST-FKBP52, but not the GST control, yielded the 
specific co-precipitation of endogenous hTERT, Hsp90 and p23, suggesting the in vivo 
existence of the hTERT-Hsp90-p23-FKBP52 heterocomplex. We also found that the 
intermediate chain of cytoplasmic dynein was precipitated by GST-FKBP52 (Fig. 3C). 
This observation suggests that dynein motor proteins could be involved in nuclear 
transport of hTERT in a FKBP52-dependent manner (see below). To determine the 
domain in hTERT that is responsible for the interaction with FKBP52, we generated a 
series of deletion fragments of TERT (Fig. 3D) and assessed binding of FKBP52 using 
the yeast two-hybrid system. We found that FKBP52 interacts with the hTERT fragments 
containing amino acid residues 595-946 (Fig. 3E). 
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Figure. 3. FKBP52 interacts with hTERT. A) GST or GST-FKBP52 were immobilized 
on glutathione-Sepharose and incubated with ectopically expressed Flag-hTERT. Bound 
proteins were detected by immunoblotting with anti-Flag antibody. The purified GST 
fusion proteins were visualized by Coomassie staining. B) H1299 cells were co-
transfected with Flag-hTERT and Myc-FKBP52 and subjected to immunoprecipitation 
with anti-Flag or anti-Myc antibodies, followed by immunoblotting to detect the 
precipitated proteins as indicated. C) GST or GST-FKBP52 were immobilized on 
glutathione-Sepharose and incubated with lysates from H1299 cells. Bound proteins were 
detected by immunoblotting with anti-hTERT, anti-Hsp90, anti0p23 and anti-dynein IC 
antibodies. D) Schematic representation of the hTERT domains involved in FKBP52 
binding. E) Analysis of the physical interaction between hTERT and FKBP52 using the 
yeast two-hybrid assay. The blue signal on the SG-HWU/X plate indicates activation of 
the reporter gene. S, synthetic; G, galactose; H, histidine (-); W, tryptophan (-); U, uracil 
(-);X, X-Gal. Rap1 was used as the TRF2-binding control. 
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4.3. The interaction between hTERT and FKBP52 requires the presence of Hsp90 
Although hTERT and FKBP52 are each able to interact with Hsp90, it is yet unclear 
whether FKBP52 alone is sufficient to interact with hTERT in the absence of Hsp90 
binding. To address this issue, we generated FKBP52 deletion constructs lacking TPR 
domain or PPIase domain and determined the region in FKBP52 that is responsible for 
hTERT binding (Fig. 4A). When H1299 cells were co-transfected with Flag-hTERT and 
various Myc-FKBP52 fragments, Flag-hTERT was immunoprecipitated only by FKBP52 
fragments containing the TPR domain, indicating that the TPR domain is responsible for 
hTERT binding (Fig. 4B). The TPR domain was also shown to be required for the 
interaction with Hsp90 (Fig. 4B). To verify this finding, we used FKBP52 mutant in 
which the lysine residue at 354 was replaced by arginine (K354A). The K354A mutation 
was shown to disrupt the interaction of FKBP52 with Hsp90 [24]. Co-
immunoprecipitation experiments revealed that the K354A mutation severely impairs the 
interaction between hTERT and FKBP52 (Fig. 4C), suggesting that the interaction 
between hTERT and FKBP52 requires the presence of Hsp90. To further analyze the 
dependence of Hsp90 on hTERT transport to the nucleus, H1299 cells expressing GFP-
hTERT were preincubated with geldanamycin (GA) to inhibit Hsp90 and subjected to 
indirect immunofluorescence staining. Under normal condition, total GFP-hTERT 
fluorescence intensity was reduced by the GA treatment compared to the untreated 
control cells (Fig. 4D). However, GA-dependent reduction in GFP-hTERT fluorescence 
was rescued by the presence of MG132, and the majority of GFP-hTERT signals was 
detected in the cytoplasm (Fig. 4D). These findings imply that Hsp90 is required for rapid 
and efficient nuclear transport of hTERT.  
It was reported in previous works that, when nuclear import is inhibited, hTERT is 
accumulated in the cytoplasm, rapidly ubiquitinated and subsequently degraded by the 
proteasome [9,12]. Because FKBP52 is required for efficient nuclear transport of hTERT 
(Fig. 1B and C), we investigated the involvement of FKBP52 depletion in hTERT 
degradation. Depletion of FKBP52 led to a clear reduction in the level of Flag-hTERT 
(Fig. 4E). This reduction in Flag-hTERT was rescued by the MG132 treatment. To 
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determine whether hTERT is ubiquitinated before its proteasome-dependent degradation, 
H1299 cells were co-transfected with Flag-hTERT and HA-ubiquitin. To illuminate 
ubiquitin-modified hTERT, anti-Flag immunoprecipitates were evaluated by 
immunoblotting with anti HA-antibody. Whereas ubiquitinated hTERT was detected in 
the control siRNA cells in the presence of MG132, depletion of FKBP52 led to a marked 
increase in the level of ubiquitinated hTERT (Fig. 4F). Taken together, these results 
suggest that nuclear import of hTERT is inhibited by FKBP52 depletion and that the 
resulting cytoplasmic hTERT is ubiquitinated prior to proteasome-dependent degradation. 
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Figure 4. The interaction between hTERT and FKBP52 requires the presence of 
Hsp90. A) Schematic representation of the FKBP52 domains involved in hTERT binding. 
B) H1299 cells were co-transfected with Flag-hTERT and various truncated Myc-
FKBP52 and subjected to immunoprecipitation with anti-Myc antibody, followed by 
immunoblotting to detect Flag-hTERT and Hsp90. C) H1299 cells were co-transfected 
with Flag-hTERT and either Myc-FKBP52 or Myc-FKBP52-K354A and subjected to 
immunoprecipitation with anti-Myc antibody, followed by immunoblotting to detect 
Flag-hTERT and Hsp90. D) H1299 cells transfected with GFP-hTERT were treated with 
or without 10 μM MG132 and 1 μM geldanamycine for 2 hr and subjected to 
immunofluorescence staining to monitor the subcellular localization of GFP-hTERT. The 
nuclei were stained with 4,6-diamidino-2-phenylindole (DAPI, blue). E) H1299 cells co-
transfected with Flag-hTERT and FKBP52 siRNA were treated with or without 10 μM 
MG132 for 2 hr and subjected to immunoblotting to detect Flag-hTERT, Hsp90 and 
FKBP52. F) H1299 cells were co-transfected with HA-ubiquitin (HA-Ub), Flag-hTERT 
and FKBP52 siRNA and treated with or without 10 μM MG132 for 2 hr. 
Immunoprecipitation was carried out with anti-Flag antibody before probing with anti-
HA antibody. 
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4.4 FKBP52 links hTERT to the dynein/dynactin motor complex 
It has been well documented that the cargo-Hsp90 heterocomplex associates with dynein 
motors, suggesting that the motor proteins are involved in the movement of cargoes to the 
nucleus on microtubule tracts [17,18]. FKBP52 interacts with cargo-bound Hsp90 
through its TPR domain as well as with the dynamitin component of the dynein-
associated dynactin complex through its PPIase domain [22]. We asked whether nuclear 
transport of hTERT is regulated by the dynein motor complex in a similar pattern as other 
cargoes. Since FKBP52 linkage to dynein is indirect through the dynamitin component, 
H1299 cells were co-transfetcted with Flag-hTERT and Myc-dynamitin and subjected to 
immunoprecipitation. Myc-dynamitin was detected in anti-Flag immunoprecipitates when 
Flag-hTERT was expressed (Fig. 5A). Myc-dynamitin associates with Flag-hTERT at a 
reduced level when FKBP52 was depleted (Fig. 5A), suggesting that the association of 
hTERT with dynamitin is mediated by FKBP52. These results demonstrate that FKBP52 
acts as the molecular linker between hTERT and the dynein motor complex.  
Overexpression of dynamitin has been shown to impair nuclear accumulation of the cargo 
proteins by inhibiting cytoplasmic dynein function [25]. To characterize the effect of 
dynamitin overexpression on nuclear transport of hTERT, H1299 cells were co-
transfected with GFP-hTERT and Myc-dynamitin and subjected to indirect 
immunofluorescence staining to determine subcellular localization of GFP-hTERT. 
Whereas GFP-hTERT was predominantly localized to the nucleus in the control cells, 
overexpression of Myc-dynamitin resulted in a clear cytoplasmic accumulation of GFP-
hTERT (Fig. 5B and C). We also measured telomerase activity by the TRAP assay. 
Overexpression of Myc-dymanitin decreased telomerase activity in a dose-dependent 
manner (Fig. 5D). These results suggest that dymanitin overexpression-dependent 
reduction in telomerase activity could be due to the decreased nuclear transport of hTERT.  
If the hTERT-Hsp90-p23-FKBP52-dynein motor complex is transported to the nucleus 
along microtubules, we would expect that treatment of cells with microtubule disrupting 
drug colchicine inhibits nuclear accumulation of hTERT. To address this possibility, 
H1299 cells were treated with colchicine and examined the subcellular localization of 
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hTERT by indirect immunofluorescence staining. Pretreatment with colchicine resulted in 
the suppression of the hTERT transport to the nucleus (Fig. 5E and F), demonstrating that 
nuclear transport of hTERT requires cytoplasmic dynein and a functional microtubule 
network. 
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Figure. 5. FKBP52 links hTERT to the dynein/dynactin motor complex. A) H1299 
cells were co-transfected with Flag-hTERT, Myc-dynamitin and FKBP52 siRNA and 
subjected to immunoprecipitation with anti-Flag antibody, followed by immunoblotting to 
detect Myc-dynamitin and Flag-hTERT. B) H1299 cells transfected with GFP-hTERT and 
Myc-dynamitin were subjected to immunofluorescence staining to monitor the 
subcellular localization of GFP-hTERT. The nuclei were stained with 4,6-diamidino-2-
phenylindole (DAPI, blue). C) After transfection, H1299 cells were subjected to 
quantitative analysis of the location of GFP-hTERT within the cells. In each experiment, 
more than 100 GFP-hTERT-expressing cells were evaluated quantitatively for nuclear (N, 
blue bars), nuclear-cytoplasmic (N+C, red bars), and cytoplasmic (C, green bars) 
fluorescence. D) H1299 cells transfected with increasing amount of Myc-dynamitin were 
analyzed for telomerase activity by the TRAP assay. To test RNA-dependent extension, 
RNase A (0.25 mg/ml) was added to the extracts before the primer extension reaction. 
ITAS represents the internal telomerase assay standard. E) H1299 cells transfected with 
GFP-hTERT were treated with 1uM of colchicine for 1 hr and subjected to 
immunofluorescence staining to monitor the subcellular localization of GFP-hTERT. The 
nuclei were stained with 4,6-diamidino-2-phenylindole (DAPI, blue). F) After 
transfection, H1299 cells were subjected to quantitative analysis of the location of GFP-
hTERT within the cells. In each experiment, more than 100 GFP-hTERT-expressing cells 
were evaluated quantitatively for nuclear (N, blue bars), nuclear-cytoplasmic (N+C, red 
bars), and cytoplasmic (C, green bars) fluorescence. 
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5. Discussion 
 
For telomere elongation by telomerase, newly synthesized hTERT should be transported 
to the nucleus and assembled with the telomerase RNA component [9]. Because the size 
of hTERT (~124 kDa) precludes a nuclear transport mechanism by passive diffusion, it 
should undergo active nuclear import pathway to set proper telomerase activity [26,27]. 
Here, we provide compelling evidence for a role of FKBP52 in the nuclear translocation 
of hTERT. We demonstrate that FKBP52 acts as a molecular linker between hTERT-
Hsp90 and the cytoplasmic dynein motor complex, favoring the cytoplasmic transport of 
hTERT to the nucleus along microtubule tracks. Indeed, depletion of FKBP52 inhibits 
nuclear import of hTERT, resulting in a cytoplasmic accumulation of hTERT. 
Cytoplasmic hTERT is degraded through ubiquitin-dependent proteolysis, thereby 
abrogating telomerase activity. Degradation of cytoplasmic hTERT is efficiently inhibited 
by the MG132 treatment, suggesting that proteasomal degradation of hTERT occurs after 
inhibition of nuclear transport. These data provide a molecular mechanism by which 
FKBP52 modulates telomerase activity. 
In this work, we show that FKBP52 interacts with the hTERT-Hsp90 heterocomplex by 
means of the TPR domain binding to Hsp90 as well as with the dynamitin component of 
the dynein-associated dynactin complex by means of the PPIase domain. These findings 
suggest that the interactions of FKBP52 with Hsp90 and dynamitin are not mutually 
exclusive. Based on our data presented in this work, we propose a model to explain how 
FKBP52 contributes to hTERT trafficking to the nucleus. In this model, FKBP52 acts as a 
scaffold to bring hTERT-bound Hsp90 (via its TPR domain) to the cytoplasmic dynein 
motor complex (via its PPIase domain) (Fig. 6). This suggests that FKBP52 performs a 
fundamental function in the nuclear translocation of hTERT. Indeed, prevention of this 
linkage by a TPR domain point mutation of FKBP52 that is unable to interact with Hsp90 
inhibits the interaction with hTERT. We also found that overexpression of dynamitin 
blocks dynein function by dissociating the motor from hTERT and impairs nuclear 
accumulation of hTERT, resulting in reduced telomerase activity. 
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It has been recently reported that hTERT contains a bipartite nuclear localization signal 
(NLS) that is responsible for nuclear import [9]. Several nuclear import receptors such as 
importin α and importin 7 have been shown to interact with hTERT through the bipartite 
NLS and mediate nuclear import of hTERT [9,28]. Redundancy in nuclear import 
pathways is observed for many other cargo substrates like ribosomal proteins and 
histones [29,30]. Likewise, it is likely that hTERT can be imported to the nucleus by 
multiple nuclear import pathways. On the other hand, the molecular chaperone network is 
essential for maintaining a balance between folding and degradation of hTERT [12]. 
When the Hsp90 and p23 molecular chaperones are assembled on hTERT, the hTERT-
Hsp90-p23 complex is linked to cytoplasmic dynein through FKBP52 and is transported 
towards the nucleus via association with microtubules. The critical question that remains 
to be answered is how the molecular chaperones modulate protein folding of hTERT for 
its nuclear transport. Possible explanation is that the association of hTERT with Hsp90 
and p23 may cause a conformational change that exposes the bipartite NLS on the protein 
surface. Upon binding to the molecular chaperones, hTERT is recognized by members of 
the importin superfamily and translocated to the nucleus via the NPC. In contrast, the 
binding of CHIP and Hsp70 to the hTERT-Hsp90-p23 complex causes dissociation of p23 
from hTERT and may induce a conformational switch that disrupts a linkage between 
FKBP52 and the hTERT-Hsp90 complex, resulting in a failure of nuclear transport of 
hTERT. It may also induce a hTERT conformation that is unable to interact with 
importins. Indeed, Hsp70 associates with hTERT but readily dissociates when telomerase 
is folded into its active form [12]. Thus, it will be interesting to explore structural and 
functional roles of multichaperone complexes assembled on hTERT in several 
intermediate assembly steps during the nuclear translocation process of hTERT. 
Although nuclear protein import is dependent on NLS within cargo proteins recognized 
by importins, microtubules have also been shown to facilitate dynein-mediated nuclear 
transport of NLS-containing cargo proteins, including p53 [31], retinoblastoma protein 
[32], parathyroid hormone-related protein [33], NF-κB [34] and dystrophin Dp71d [35]. 
In a similar manner to other systems, cells treated with microtubule-perturbing drug 
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colchicine showed reduced movement of hTERT towards the nucleus, implying the 
microtubule-dependent nuclear transport of hTERT. It has been previously shown that, 
following microtubule-dependent trafficking towards the nucleus, a cargo can be released 
from microtubules and recognized by importins prior to nuclear import [36]. As proposed 
in other NLS-containing cargo proteins, our results suggest that importins may compete 
with microtubule for hTERT binding. The bipartite NLS of hTERT could be recognized 
by importins near the nuclear periphery, dissociating hTERT from dynein and 
subsequently mediating nuclear import through the NPC. 
In this study, we identify Hsp90-binding immunophilin FKBP52 as a molecular linker 
between hTERT-Hsp90 and the dynein motor complex and characterize a mechanism 
underlying dynein/microtubule-dependent nuclear transport of hTERT. FKBP52 links 
directly the hTERT-Hsp90 complex to dynamitin, which in turn connects this complex to 
the dynein motor prior to microtubule-dependent movement towards the nucleus. This 
nuclear transport model of hTERT provides a new route for modulating telomerase 
activity by regulating its nuclear import efficiency in human cancer cells. 
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Figure. 6. Model for FKBP52-mediated nuclear transport of hTERT. FKBP52 links 
the hTERT-hsp90 complex to dynein for cytoplasmic transport of hTERT to the nucleus 
along microtubule tracks. 
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NEDD8 ultimate buster-1 (NUB1) 
promotes the proteasome-mediated 
proteolysis of TRF1 
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1. Abstract 
 
The human telomeric protein TRF1 is one of the telomere-associated proteins, 
which is coated at the chromosome ends to protect telomere. In particular, TRF1 
negatively regulates telomere extension by inhibiting telomerase access to the ends of 
the telomeres, suggesting that the TRF1 at the telomeres is tightly regulated for 
controlling telomere length. Here, we identified NEDD8 Ultimate Burster1 (NUB1), 
a negative regulator of the NEDD8 conjugation system, by recruiting free NEDD8 
and its conjugates to the proteasome for degradation as a novel TRF1-interacting 
protein. NUB1 interacts with TRF1 in vitro and in vivo through its N-terminal region 
in an NEDD8-independent manner. We found that overexpression of NUB1 
decreased levels of TRF1 and also reduced the half-life of TRF1, whereas depletion 
of endogenous NUB1 expression stabilized levels of endogenous TRF1. A previous 
report found that the ubiquitin-like domain at the N-terminal region of NUB1 
interacted with the 26S proteasome subunit (S5a/PSMD4). We also found that the 
interaction between TRF1 and PSMD4 was enhanced by NUB1 overexpression, but 
decreased by NUB1 knockdown, suggesting that NUB1 might play an adaptor role 
between TRF1 and proteasome for degradation. These findings demonstrate that 
NUB1 plays a critical role in controlling the proteasomal degradation of TRF1 
through physical interaction for telomere homeostasis. 
                                                                         
Keywords : Telomere, TRF1, NUB1, UBL-UBA protein family, S5a/PSMD4, 
proteasomal degradation 
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2. Introduction 
 
Telomeres are specialized nucleoprotein complexes found at the end of linear eukaryotic 
chromosomes required for genome integrity [1]. Mammalian telomeric DNA is composed 
of tandem TTAGGG repeats bound by a series of associated proteins which are required 
for the protection and maintenance of telomeres from being recognized as double-strand 
DNA breaks [2,3]. Most human normal somatic cells show a progressive loss of telomeric 
DNA during successive rounds of cell division due to a DNA end-replication problem [4]. 
However, in most tumor cells, steady-state telomere length is tightly regulated by 
telomerase which is a specialized reverse transcriptase that adds DNA to the chromosome 
termini to compensate for telomere loss during DNA replication. These observations 
suggest that abnormal telomere shortening or elongation is implicated in aging and cancer. 
Telomere homeostasis is regulated by telomerase and the six-subunit protein complex 
named shelterin, which consists of TRF1, TRF2, POT1, TIN2, TPP1, and Rap1 [5,6]. The 
shelterin complex plays an essential role in maintaining the integrity of telomere length 
and structure. Among the shelterin components, both TRF1 and TRF2 bind to duplex 
telomeric DNA as dimers though the C-terminal DNA-binding motif that is closely 
related to the Myb domain and an internal conserved TRF homology domain. TRF2 is 
best known for its role in telomere protection, and it stabilizes a terminal loop structure 
called the t-loop [7]. In comparison, TRF1 negatively regulates telomerase-dependent 
telomere extension by inhibiting telomerase access to the ends of telomeres. The 
overexpression of TRF1 accelerates telomere shortening whereas the loss of TRF1 from 
telomeres has been shown to induce telomerase-dependent telomere elongation, implying 
that the cellular amount of TRF1 on telomeres should be tightly regulated for maintaining 
telomere length [8,9].  
TRF1 is subject to extensive post-translational modification [10] and it is evident that 
the abundance of TRF1 has been shown to be regulated through interactions with various 
proteins. We have previously identified casein kinase 2 (CK2) as a TRF1-interacting 
protein, and CK2-mediated phosphorylation is required for the efficient telomere binding 
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of TRF1, suggesting the role of CK2 in determining the level of TRF1 at the telomeres 
[11]. Polo-like kinase 1 also interacts and phosphorylates TRF1 and is involved in both 
TRF1 overexpression-induced apoptosis and the telomere-binding ability of TRF1 [12]. 
Moreover, Pin1 has been shown to be an essential regulator of TRF1 stability [13] and 
guanine nucleotide-binding protein-like 3 (GNL3L) has also been reported to bind and 
stabilize TRF1 protein by inhibiting its ubiquitination and binding to Fbx4 [14]. On the 
other hand, tankyrase 1, which is a member of the poly(ADP-ribose) polymerase (PARP) 
family, has been shown to interact with the acidic domain in the N-terminus of TRF1. The 
ADP-ribosylation of TRF1 by tankyrase1 dissociates TRF1 from telomeres, thus enabling 
telomerase access to the telomeres and resulting in telomere elongation [15,16]. The 
dissociated telomere-unbound TRF1 by the activation of tankyrase 1 is rapidly 
ubiquitinated by E3 ubiquitin ligases, such as Fbx4 [17] and RLIM [18], and 
subsequently degraded by the proteasome. 
In this study, we identified NEDD8 ultimate buster-1 (NUB1) as a novel TRF1-
interacting protein using yeast two-hybrid screening. NUB1 is an interferon-inducible 
protein and possesses a UBL (ubiquitin-like) domain at the N-terminal region and two 
ubiquitin-associated domains at the C-terminus [19,20]. Previously, NUB1 has been 
shown to directly interact with NEDD8 (neural precursor cell expressed developmentally 
down-regulated 8), which is an ubiquitin-like modifier, and PSMD4, which is a 26S 
proteasome subunit [20,21,22]. Thus far, the crucial function of NUB1 is the recruitment 
of the NEDD8 and NEDD8-conjugated protein to the 26S proteasome for degradation 
[19,20,23]. Here, we showed that NUB1 promotes TRF1 degradation by enhancing the 
interaction between TRF1 and 26S proteasome. These findings suggest that NUB1 is a 
negative regulator of TRF1 protein level and represents a new pathway for modulating 
TRF1 function at the telomeres. 
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3. Materials and Methods 
 
3.1 Yeast Two hybrid Screening 
Yeast two-hybrid screening was performed as described [24]. Briefly, the full-length 
TRF1 cDNA was fused to the LexA DNA binding domain and transformed by the lithium 
acetate method into the EGY48 yeast strain. Expression of the LexA-TRF1 fusion protein 
was verified by Western blotting using anti-LexA antibody. The stable strain was 
transformed again with a HeLa cDNA library fused to the activation domain vector 
pB42AD (Clontech). 
 
3.2 Cell culture and plasmids construction 
The human embryonic kidney cell line HEK293 were cultured in Dulbecco’s modified 
Eagle’s medium supplemented with 10% fetal bovine serum, 100units/ml penicillin, and 
100μg/ml streptomycin in 5% CO2 at 37°C. The expression vectors for Flag-TRF1, Myc-
NUB1, V5-FBX4, were constructed by inserting the full-length cDNAs into pRK5-Flag, 
pRK5-Myc and pRK5-V5(Stratagene), respectively. The expression vectors for GST-
TRF1 and GST-NUB1 were constructed by cloning the full-length and truncated 
fragments from the TRF1 or NUB1 cDNA into pGEX-4T-2 (GE Healthcare).. The GST 
fusion proteins were expressed and purified by using a glutathione-Sepharose 4B 
according to the manufacturer's instructions (Amersham Biosciences, Piscataway, NJ). 
 
3.3 GST Pull down, Immunoprecipitation, immunoblotting and antibodies 
The expression vectors were transiently transfected into HEK293 cells using 
Lipofectamine 2000 reagent according to the manufacturer’s protocol (Invitrogen) for 24 
h followed by lysis. For GST pull down assay, lysates were precleared with glutathione-
Sepharose 4B (Amersham Biosciences) and incubated with glutathione-Sepharose beads 
containing GST fusion proteins for 2 h at 4°C. For immunoprecipitation, lysates were 
preincubated with protein A-Sepharose (Amersham Biosciences) and incubated with anti-
Flag (Sigma) or anti-Myc (Santa Cruz Biotechnology) antibodies precoupled with protein 
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A-Sepharose beads for 2 h at 4°C. Bound proteins were analyzed by SDS-PAGE, 
followed by immunoblotting. Immunoblotting were performed using anti-Flag (Sigma), 
anti-Myc (Santa Cruz Biotechnology), anti-NUB1 (Santa Cruz Biotechnology), anti-
NEDD8 (Cell signaling), anti-tubulin (Santa Cruz Biotechnology) and anti-hTRF1#370 (a 
gift from Titia de Lange, Rockefeller University) antibodies as specified. All the 
immunoblots are representatives of at least three experiments that demonstrated the 
similar results. 
 
3.4 RNA interference 
The siRNA duplexes were transfected into HEK293 cells using Lipofectamine2000 
transfection reagent (Invitrogen). The siRNA target sequences specific for NUB1 were 
5’-ACCGTACTTAGACATAGCTAA-3’ for siNUB1-1 and 5’-
TAGAGGCTTATGAGTATCTTA -3’ for siNUB1-2. The siRNA target sequences specific 
for NEDD8 were 5’-CATAATGAG GCATCATATA-3’. The scrambled sequence (5’-
AATCGCATAGCGTATGCCGTT-3’) was used as a negative control and did not 
correspond to any known gene in the data bases. 
 
3.5 In vivo ubiquitination assay 
HEK293 cells were co-transfected with Flag-TRF1 and HA-ubiquitin and treated with 
10 µM MG132 to inhibit proteasome function. Lysates were subjected to 
immunoprecipitation with anti-Flag M2 affinity resins (Sigma), followed by 
immunoblotting with anti-HA antibody to illuminate ubiquitin-conjugated TRF1. 
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4. Results 
 
4.1 Identification of NUB1 as a TRF1-interacting partner 
To identify TRF1-interacting factors, we screened a HeLa cell cDNA library using the 
yeast two-hybrid system. Using the full-length TRF1 as bait, 26 positive clones were 
obtained and sequenced. One of the isolated clones contained the cDNA encoding NUB1 
(NEDD8 ultimate buster-1) (Fig. 1A), which was identified as a negative regulator of the 
NEDD8 conjugation system by recruiting NEDD8 and its conjugates to the proteasome 
for degradation [19-21, 25]. RAP1, which was known to interact with TRF2[26], and 
PINX1, which was known to interact with TRF1[27], were used as positive controls. To 
confirm the direct interaction between TRF1 and NUB1, we performed GST pull-down 
experiments. GST-NUB1, but not the control GST, precipitated Flag-TRF1 expressed in 
HEK293 cells, indicating that TRF1 interacts with NUB1 in vitro (Fig. 1B). Likewise, 
GST-TRF1, but not the control GST, precipitated Myc-NUB1 expressed in HEK293 cells. 
To determine whether TRF1 and NUB1 associate in vivo, HEK293 cells were co-
transfected with Flag-TRF1 and Myc-NUB1 expression vectors and subjected to 
immunoprecipitation. Flag-TRF1 was detected in anti-Myc immunoprecipitates when 
Myc-NUB1 was expressed (Fig. 1C). Likewise, Myc-NUB1 was recovered in anti-Flag 
immunopecipitates when Flag-TRF1 was expressed. To further substantiate the direct 
interaction between TRF1 and NUB1, we performed GST-pull down experiments with 
purified proteins. As expected, His-TRF1 was precipitated with GST-NUB1, but not the 
control GST (Fig. 1D). It has been well documented that NUB1 can interact with NEDD8 
directly and reduce the free NEDD8 and NEDD8-conjugates through proteasomal 
degradation. To examine whether the interaction between TRF1 and NUB1 in vivo was 
NEDD8-dependent, HEK293 cells were co-transfected with Flag-TRF1, Myc-NUB1 and 
NEDD8 siRNA and subjected to immunoprecipitation. The interaction between Myc-
NUB1 and Flag-TRF1 was not affected much when NEDD8 was depleted (Fig. 1E). 
These results suggest that NUB1 can interact with TRF1 in an NEDD8-independent 
manner. 
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Figure 1. NUB1 interacts with hTERT in vitro and in vivo. (A) Analysis of the 
physical interaction between TRF1 and NUB1 using the yeast two-hybrid assay. PinX1, 
RAP1, and unrelated FKBP52 were used as the TRF1-binding, TRF2-binding, and 
negative control, respectively. The growth on the SG-HWUL plate and the blue signal on 
the SG-HWU/X plate indicate activation of the reporter genes, LacZ and LEU2, 
respectively. S, synthetic; G, galactose; H, histidine (-); W, tryptophan (-); U, uracil, (-); 
L, leucine (-); X, 5-bromo-4-chloro-3-indolyl-β-d-galactopyranoside (X-gal) (B) GST, 
GST-NUB1 and GST-TRF1 were immobilized on glutathione-Sepharose and incubated 
with ectopically expressed Flag-TRF1 or Myc-NUB1. Bound proteins were detected by 
immunoblotting with anti-Flag or anti-Myc antibodies. (C) HEK293 cells were co-
transfected with Flag-TRF1 and Myc-NUB1 and subjected to immuno-precipitation with 
anti-Myc or anti-Flag antibodies, followed by immunoblotting with anti-Flag or anti-Myc 
antibodies. (D) GST, GST-NUB1 were immobilized on glutathione-Sepharose and 
incubated with purified His-TRF1. Bound proteins were detected by immunoblotting with 
anti-His antibody. (E) HEK293 cells were co-transfected with Flag-TRF1, Myc-NUB1 
and NEDD8 siRNA and subjected to immunoprecipitation with anti-Flag antibody, 
followed by immunoblotting to detect Myc-NUB1. 
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4.2 Identification of the domains in TRF1 and NUB1 required for their interactions 
NUB1 consists of an ubiquitin-like (UBL) domain as a proteasome-interacting motif, an 
ubiquitin-associated (UBA) domain as a ubiquitin-related motif, and a pest domain as an 
NEDD8-interacting domain. To map the region in NUB1 responsible for TRF1 binding, 
we generated NUB1 deletion constructs lacking UBL or UBA domains (Fig. 2A). 
HEK293 cells were co-transfected with Flag-TRF1 and Myc-NUB1 or its truncate 
constructs and subjected to immunoprecipitation with anti-Flag antibody. Full-length of 
NUB1 and its N-terminal fragment (1-346) were bound to Flag-TRF1 (Fig. 2B). We also 
confirmed their interaction using in vitro binding assay with GST-fused full-length NUB1 
and NUB1 truncates. Likewise, Flag-TRF1 was precipitated with GST-NUB1 and GST-
NUB1-N(1-346), but not GST-NUB1-C(346-601) and control GST (Fig. 2C). These 
results indicate that TRF1 interacts with the N-terminal region containing the UBL 
domain in NUB1. Next, several Flag-tagged TRF1 fragments were tested for their 
interaction with NUB1 in vivo (Fig. 2D). HEK293 cells were co-transfected with Myc-
NUB1 and various Flag-TRF1 fragments and subjected to immunoprecipitation. Full-
length TRF1, TRF1-D2(1-263), and TRF1-D5(1-377) containing acidic domains were 
bound to Myc-NUB1, suggesting that the acidic domain of TRF1 is important for NUB1 
binding (Fig. 2E). Domain study showed that N-terminal region of NUB1 and the acidic 
domain of TRF1 were responsible for their interaction. 
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Figure 2. Identification of the domains in NUB1 and TRF1 required for their 
interaction. (A) Schematic representation of NUB1 and its deletion variants used in this 
study. (B) HEK293 cells were co-transfected with Flag-TRF1 and various Myc-NUB1 
and subjected to immunoprecipitation with anti-Myc antibody, followed by 
immunoblotting with anti-Flag antibody. (C) GST, GST-NUB1 variants were immobilized 
on glutathione-Sepharose and incubated with ectopically expressed Flag-TRF1. Bound 
proteins were detected by immunoblotting with anti-Flag antibody. (D) Schematic 
representation of TRF1 and its deletion variants (E) HEK293 cells were co-transfected 
with various Flag-tagged TRF1 and Myc-NUB1 and subjected to immunoprecipitation 
with anti-Flag antibody, followed by immunoblotting with anti-Myc antibody. 
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4.3 NUB1 promotes TRF1 recruitment to proteasome for degradation through 
S5a/PSMD4 
Ubiquitin-mediated proteasomal degradation is one of the major mechanisms involved 
in the maintenance of the proper levels of cellular proteins. The 26S proteasome 
holoenzyme consists of two major subunits, the 19S regulatory particle (RP) and the 20S 
core particle (CP) [28]. Specific subunits of the proteasome 19S RP have been identified 
as ubiquitin receptors that are capable of recognizing both free ubiquitin and ubiquitin-
conjugated proteins, and the most studied proteasome ubiquitin receptor is S5a/PSMD4. 
It has been well documented that the ubiquitin-like–ubiquitin-associated (UBL–UBA) 
family of proteins regulates its interacting protein by promoting or inhibiting proteasomal 
degradation [29]. Both components interact with S5a/PSMD4 via its UBL domain and 
ubiquitin and ubiquitinated proteins via its UBA domain. A previous report stated that 
NUB1 directly interacts with S5a/PSMD4, which is a subunit of the 26S proteasome 
through its UBL domain, and it was shown that the C terminus of NUB1L binds to 
S5a/PSMD4 [21]. Another study reported the association of NUB1L with S5a/PSMD4 
via the N-terminal UBL domain [30, 31]. Because we found NUB1 directly interacts with 
TRF1, we hypothesized that NUB1 mediates the recruitment of TRF1 to the proteasome 
through its UBL domain. First, to confirm the interaction between NUB1 and 
S5a/PSMD4 in vivo, HEK293 cells were co-transfected with GFP-PSMD4 and various 
Myc-NUB1 truncates and subjected to immunoprecipitation with the anti-Myc antibody, 
followed by immunoblotting using the anti-GFP antibody. As expected, NUB1 was 
associated with PSMD4 through its N-terminal region containing the UBL domain in 
accordance with the latter report (Fig. 3A). To examine whether NUB1 contributes to the 
interaction between TRF1 and the 26S proteasome, HEK293 cells were co-transfected 
with Flag-TRF1, Myc-NUB1, and GFP-PSMD4 expression vectors and treated with 
10uM of MG132 for 2hrs. Lysates were subjected to immunoprecipitation with anti-Flag 
or anti-GFP antibodies, followed by immunoblotting using anti-GFP or anti-Flag 
antibodies, respectively. The interaction between Flag-TRF1 and GFP-PSMD4 was 
increased by the overexpression of NUB1 (Fig. 3B, 3C). On the other hand, NUB1 
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depletion led to a clear reduction of the association between Flag-TRF1 and GFP-PSMD4, 
suggesting that NUB1 acts as a physical linker between TRF1 and S5a/PSMD4 through a 
UBL domain at its N-terminal region for recruiting TRF1 to proteasome (Fig. 3D). 
 
 
Figure 3. NUB1 act as a physical linker between the TRF1 and the S5a/PSMD4 (A) 
HEK293 cells were transfected with GFP-PSMD4 and Myc tagged NUB1 variants and 
subjected to immunoprecipitation with anti-Myc antibody, followed by immunoblotting 
with anti-GFP antibody. (B) HEK293 cells were transfected with GFP-PSMD4, Flag-
TRF1 and Myc-NUB1 and treated with 10μM MG132 for 4 hours, and subjected to 
immunoprecipitation with anti-Flag antibody, followed by immunoblotting with anti-GFP 
or anti-Flag antibodies. (C) HEK293 cells were transfected with GFP-PSMD4, Flag-
TRF1 and Myc-NUB1 and treated with 10μM MG132 for 4 hours, and subjected to 
immunoprecipitation with anti-GFP antibody, followed by immunoblotting with anti-Flag 
antibodies (D) HEK293 cells were co-transfected with Flag-TRF1, Myc-NUB1 at 48h 
post-transfection with NUB1 siRNA(50nM) and treated with 10μM MG132 for 4 hours, 
and subjected to immunoprecipitation with anti-Flag antibody, followed by 
immunoblotting with anti-GFP or anti-Flag antibodies. 
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4.4 NUB1 down-regulates TRF1 levels and stability 
In earlier studies, the characterized function of NUB1 was recruiting NEDD8 and 
NEDD8 conjugates to proteasome for degradation [19, 20, 23]. However, our results 
showed that the interaction between TRF1 and NUB1 occurred in an NEDD8-indepenent 
manner. To examine whether NUB1 contributes to the levels of TRF1 in vivo, HEK293 
cells were co-transfected with Flag-TRF1 and increasing doses of Myc-NUB1 and 
analyzed using immunoblotting with the anti-Flag antibody. The expression levels of 
Flag-TRF1 were decreased by NUB1 in a dose-dependent manner (Fig. 4A). Although 
the NEDD8-dependent mechanism of TRF1 has not yet been reported, to eliminate this 
possibility, we used MLN4924, which is the selective inhibitor of the NEDD8-Activating 
Enzyme (NAE) [32]. HEK293 cells were co-transfected with HA-TRF1 and increasing 
doses of Myc-NUB1 and treated with or without 1uM of MLN4924 for 20hrs and 
analyzed using immunoblotting with the anti-HA antibody. Interestingly, the expression 
levels of HA-TRF1 were decreased by NUB1 in a dose-dependent manner even when 
MLN4924 was treated (Fig. 4B). These data suggest that NUB1 reduces the level of 
TRF1 in an NEDD8-independent manner. Furthermore, we also examined the stability of 
TRF1 by NUB1 overexpression. HEK293 cells were co-transfected with Flag-TRF1 and 
Myc-NUB1 and treated with cycloheximide (100ug/ml) as indicated time to block new 
protein synthesis and analyzed using immunoblotting with the anti-Flag antibody. As 
shown in Fig. 4C and graphically in Fig. 4D, the overexpression of Myc-NUB1 reduced 
the half-life of TRF1 compared with the empty vector-expressing cells. Myc-Fbx4, which 
is a TRF1-specific ubiquitin E3 ligase, was used as a control [17, 33]. In all cases, the 
turnover of TRF1 was blocked by the MG132 treatment, indicating that the degradation 
of TRF1 was mediated by the proteasome. To further verify the involvement of NUB1 in 
regulating the levels of endogenous TRF1, we transiently expressed increasing doses of 
Myc-NUB1 in HEK293 cells and examined the levels of endogenous TRF1. The levels of 
endogenous TRF1 substantially decreased in Myc-NUB1-expressing cells compared with 
the empty vector-expressing cells (Fig. 4E). Myc-Fbx4 expression vector was used as a 
positive control. Additionally, to examine the effect of NUB1 on endogenous TRF1, the 
expression of endogenous NUB1 was depleted using two different small interfering RNA 
(siRNA) duplexes. The levels of endogenous TRF1 increased in the NUB1-depleted cells 
compared with the control cells (Fig. 4F). However, no significant difference was 
observed in the steady-state levels of TRF1 mRNA between NUB1 knockdown or over-
expressing cells and the control cells (Fig. 4G). Taken together, these results suggest that 
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NUB1 modulates the cellular abundance and half-life of endogenous TRF1 by acting as a 
negative regulator of the TRF1 protein. 
 
 
 
Figure 4. NUB1 down-regulates the TRF1 level and Stability. (A) HEK293 cells were 
co-transfected with Flag-TRF1 and increasing amounts of Myc-NUB1 as specified. The 
levels of ectopically expressed Flag-TRF1 and Myc-NUB1 were determined by 
immunoblotting with anti-Flag and anti-Myc antibodies, respectively. An antibody against 
tubulin was used as a loading control. (B) HEK293 cells were co-transfected with Flag-
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TRF1 at 48h post-transfection with increasing amounts of NUB1 siRNA. Lysates were 
analyzed on immunoblots with anti-Flag or anti-tubulin antibodies. (C) HEK293 cells 
were transfected with Flag-TRF1, Myc-NUB1 or Myc-Fbx4 and treated with 100μg/ml 
cycloheximide together with, or without, 10μM of MG132 for the indicated times. The 
levels were analyzed on immunoblots with anti-Flag and anti-Myc antibodies. An 
antibody against tubulin was used as a loading control. (D) Graphical representation of 
the relative TRF1 levels normalized against the tubulin loading control. The TRF1 
expression levels were quantified with the average and standard deviation from three 
independent experiments. (E) HEK293 cells were transfected with Myc-NUB1 or Myc-
Fbx4 as indicated. The levels endogenous TRF1, Myc-NUB1 and, Myc-Fbx4 were 
determined by immunoblotting with anti-TRF1(#370) and anti-Myc antibodies, 
respectively. (F) HEK293 cells transfected with two different NUB1 siRNA duplexes and 
lysates were analyzed by immunoblotting using anti-TRF1(#370) and anti-NUB1 
antibodies, respectively. (G) HEK293 cells transfected with Myc-NUB1 or NUB1 
siRNAs were subjected to reverse transcription-PCR analysis for the mRNA levels of 
endogenous TRF1 and TRF2 genes. 
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4.5 Degradation of TRF1 by the 26S proteasome relies on NUB1 in a ubiquitin-
independent manner 
NUB1 is a unique member of the UBL–UBA family that interacts with NEDD8 instead 
of ubiquitin. Previous reports demonstrated that FAT10, which is the only ubiquitin-like 
modifier, can target proteins for degradation by the proteasome in a ubiquitin-
independent manner [34, 35], and the degradation of FAT10 and FAT10 conjugates is 
accelerated by NUB1L [30, 31, 35]. We also identified that TRF1 is recruited to the 26S 
proteasome by NUB1. Next, we examined whether the ubiquitination of TRF1 is affected 
by the presence of NUB1. HEK293 cells were co-transfected with Flag-TRF1, Myc-
NUB1, V5-Fbx4, and HA-Ubiquitin, treated with 10uM of MG132 for 4hrs, and 
subjected to immunoprecipitation with the anti-Flag antibody, followed by 
immunoblotting using the anti-HA antibody to illuminate ubiquitin-modified TRF1. 
Interestingly, we found that the ubiquitination of TRF1 was reduced by the 
overexpression of NUB1 even when Fbx4 was co-expressed (Fig. 5A). Furthermore, we 
confirmed the in vivo ubiquitination of TRF1 under denaturing conditions. HEK293 cells 
were co-transfected with HA-TRF1, Myc-NUB1, Myc-Fbx4, and His-Ubiquitin 
expression vectors and treated with 10uM of MG132 for 4hrs. Lysates were precipitated 
under denaturing conditions using Ni-NTA pull-down and the ubiquinated-TRF1 was 
analyzed through immunoblotting using the HA antibody. Consistently, the ubiquitination 
of TRF1 was decreased by NUB1, suggesting that NUB1 down-regulates TRF1 in a 
ubiquitin-independent manner (Fig. 5B). 
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Figure 5. Degradation of TRF1 by the 26S proteasome relies on NUB1 in a 
ubiquitnation-independent manner. (A) HEK293 cells were co-transfected with Flag-
TRF1, HA-Ubiquitin, Myc-NUB1 and V5-Fbx4 and treated with 10μM of MG132. 
Lysates were subjected to immunoprecipitation with anti-Flag antibody, followed by 
immunoblotting using anti-HA antibody to detect Ubiquitin-conjugated TRF1. (B) 
HEK293 cells were transfected with His tagged Ubiquitin, HA-TRF1, Myc-NUB1 and 
Myc-Fbx4 as indicated, and performed Ni-NTA pull-down under denature condition 
followed by immunoblotting using anti-HA antibody. 
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5. Discussion 
 
TRF1 negatively regulates the telomere length by restricting telomerase access to the 
telomeres. The overexpression of TRF1 promotes telomere shortening, whereas the loss 
of TRF1 from the telomeres has been shown to induce abnormal telomere elongation [8], 
suggesting that an abundance of TRF1 at the telomeres should be tightly controlled for 
maintaining telomere length. Therefore, the cellular levels of TRF1 at the telomeres has 
been shown to be tightly regulated by interactions with various proteins, such as 
tankyrase 1, Fbx4, RLIM, CK2, Pin1, and Plk1 [10]. Here, we describe a novel function 
of NUB1 for regulating the abundance of TRF1 in mammalian cells. We identified NUB1 
as a negative regulator of TRF1 by directly interacting with TRF1. The overexpression of 
NUB1 significantly decreased the levels of TRF1 and also reduced the half-life of TRF1, 
whereas the depletion of NUB1 by the RNA interference stabilized the endogenous TRF1. 
These findings demonstrate that NUB1 plays a critical role in regulating the level of 
TRF1 at the telomeres.  
NUB1 is composed of several domains, including the ubiquitin-like domain, two 
ubiquitin-associated domains, a bipartite nuclear localization signal, and a PEST 
sequence, and it is a unique member of the UBL–UBA family that interacts with NEDD8 
instead of ubiquitin [19, 20]. To explain the function of NUB1 on TRF1, there are several 
possibilities. The first possibility is that TRF1 is the target for NEDD8 conjugation, 
resulting in NEDD8-conjugated TRF1 being recruited by NUB1 to the 26S proteasome 
for degradation. Although TRF1 is subject to extensive post-translational modification 
[10], the NEDD8 conjugation of TRF1 has not yet been determined, and we found that 
the interaction between TRF1 and NUB1 was not affected by the depletion of endogenous 
NEDD8 (Figure 1E), implying that the interaction between NUB1 and TRF1 occurs in an 
NEDD8-independent manner. Unexpectedly, we also found that the MLN4924 treatment 
dramatically increased the level of TRF1, suggesting that further study is required to 
assess the biological function of the NEDD8-dependent mechanism of TRF1. The second 
possibility is that NUB1 is an adaptor between S5a of the 19 S proteasome and TRF1. A 
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previous report has shown that NUB1 interacts with NEDD8 and NEDD8-conjugates 
through its PEST domain in the C-terminus and also interacts with S5a through its UBL 
domain in the N-terminus [19-21, 31]. Based on our findings on the physical association 
between NUB1 and TRF1, we focus on the second possibility for determining the NEDD-
independent functions of NUB1 on TRF1 in this study. 
A recent study suggested that the UBL–UBA protein family, which has an N-terminal 
ubiquitin-like (UbL) domain and one or more ubiquitin-associated (UBA) domains, has a 
role in proteasomal degradation. This is because both components interact with 
S5a/PSMD4, a subunit of the 19S proteasome activator (via the UBL domain), and the 
proteins are targeted for degradation by ubiquitination (via the UBA domain) [29]. 
Several UBL–UBA domain proteins have been well characterized, such as Rad23 [36-38], 
BAG-1 [39], Dsk2 [40]. Rad23 interacts with S5a through an N-terminal UBL domain, 
and the C terminus of Rad23 binds to the ubiquitinated Rad4 DNA repair protein and 
creates a link between the DNA repair and proteasome pathways [41]. BAG-1 has also 
been shown to play a role in the physical link between the molecular chaperones 
Hsc70/Hsp70 and the proteasome through a UBL domain at its N-terminal region [39]. 
Since NUB1 also possesses a ubiquitin-like domain at its N-terminal region and 
physically interacts with S5a/Rpn10 [21], we hypothesized that NUB1 might act as a 
linker between the TRF1 and the S5a subunit of the 19S proteasome activator through its 
UBL domain. Based on this hypothesis, we found that the association between TRF1 and 
S5a/PSMD4 was enhanced by the overexpression of NUB1 and reduced by the depletion 
of NUB1, suggesting that NUB1 could serve as a direct link between TRF1 and 
proteasomal degradation. Moreover, we found that although the level of TRF1 was 
decreased by NUB1, the ubiquitination of TRF1 was reduced by the overexpression of 
NUB1, implying that the overexpression of NUB1 induces the degradation of TRF1 by 
NUB1 prior to ubiquitin-mediated proteolysis. Therefore, we suggest that the NUB1-
dependent-ubiquitin-independent pathway functions differently in a ubiquitin-
independent manner for regulating the cellular abundance of TRF1. 
In summary, our data provide evidence for the novel function of NUB1 in modulating 
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the cellular abundance of TRF1 through cooperation with proteasome. The key findings 
of this study suggest a new mechanism for the degradation of TRF1 by NUB1 through a 
ubiquitin-independent pathway. Although many important questions about the biological 
significance of the NUB1 function at the telomeres in regulating TRF1 remain unresolved, 
our data suggest that NUB1 represents a new pathway for controlling the stability of 
TRF1 by acting as a negative regulator of TRF1. 
 
 
 
 
 
 
Figure 6. Model for NUB1-mediated proteolysis of TRF1 
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1. Abstract 
 
A telomere is a specialized heterochromatic structure found at the end of eukaryotic 
chromosomes. It is composed of telomeric DNA and a six-subunit protein complex, 
named shelterin, which is required for maintaining and protecting the telomere 
from nucleolytic attacks. Human TRF1 is one of the shelterin proteins directly 
involved in telomere length regulation. Post-translational modifications of TRF1 
play important roles in modulating telomere length homeostasis by regulating the 
abundance of TRF1 at telomeres through the interactions with various proteins. 
Here, we demonstrate the novel post-translational modification of TRF1 called 
neddylation. We find that TRF1 is subject to NEDD8-conjugation in vitro and in vivo, 
and we also identify and characterize NEDP1, which is a human NEDD8-specific 
protease that efficiently abolishes the neddylation of TRF1. NEDD8 fusion to the C-
terminus of TRF1 to mimic the effects of mono-neddylation is found to cause the 
cytoplasmic localization of TRF1 and reduce the stability of TRF1, suggesting that 
the neddylation of TRF1 is involved in the subcellular localization and cellular 
abundance of TRF1. Moreover, the level of TRF1 is increased and cytoplasmic 
localization is inhibited by MLN4924 treatment, which is a novel NEDD8-Activating 
Enzyme (NAE) inhibitor, implying that neddylation is a novel post-translational 
modification mechanism for controlling TRF1 at telomeres. 
                                                           
Keywords: hTRF1, NEDD8, Ubiquitin, Neddylation, Ubiquitination, post-translational 
modification 
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2. Introduction 
 
Telomeres, the specialized nucleoprotein complexes found at the ends of linear 
chromosomes, are essential for chromosome integrity [1]. Properly capped telomeres 
protect chromosome termini from being recognized as DNA double strand breaks, and the 
dysfunction of telomeres has been implicated in numerous human diseases and disorders, 
such as diseases linked to aging and cancer [1, 2]. Mammalian telomeres consist of 
TTAGGG tandem repeats, and telomeric DNA is closely linked to the six-subunit protein 
complex named shelterin (TRF1, TRF2, POT1, TIN2, TPP1, and Rap1), which is 
required for maintaining the telomere structure [2-4]. TRF1 and TRF2 are double-
stranded telomeric DNA-binding proteins, whereas POT1 binds to the single-stranded G-
rich overhang. Other shelterin components are recruited to telomeres through the 
interactions with TRF1, TRF2, and POT1 [6,7]. The maintenance of functional telomeres 
requires telomerase, a unique ribonucleoprotein enzyme that contains telomerase reverse 
transcriptase (TERT), which can counteract the loss of terminal sequences during DNA 
replication [5]. However, other solutions to the end replication problem have been 
documented, generally involving a homologous recombination (HR) mechanism known 
as alternative lengthening of telomeres (ALT). Maintenance of the telomere length at 
human chromosome ends, either by telomerase or an alternative mechanism (ALT), is 
essential to the long-term replicative survival of cells [6].  
Among the telomeric proteins, TRF1 and TRF2 directly bind to the double-stranded 
telomeric repeats and interact with a number of proteins to maintain telomere structure 
and length [7]. Both proteins contain a C-terminal DNA-binding motif that is closely 
related to the Myb domain and an internal conserved TRF2 homology domain that 
mediates dimerization [8]. TRF2 has an essential role in end protection and stabilizes a 
terminal loop structure called the t-loop [9]. TRF1 is a negative regulator of telomere 
lengthening by telomerase. Overexpression of TRF1 accelerates telomere shortening, 
whereas a loss of TRF1 from telomeres has been shown to induce inappropriate telomere 
elongation [10].  
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Post-translational modifications of TRF1 play a critical role in modulating telomere 
length homeostasis by regulating the abundance of TRF1 at telomeres through the 
interactions with various proteins [11]. We have previously identified casein kinase 2 
(CK2) as a TRF1-interacting protein [12]. CK2-mediated phosphorylation is required for 
the efficient telomere binding of TRF1 and important for TRF1-mediated telomere length 
control. It has also been reported that the ability of TRF1 to bind telomeric DNA is 
increased by Polo-like kinase 1 (Plk1)-mediated phosphorylation [13]. In addition, ataxia 
telangiectasia mutated(ATM) interacts with and phosphorylates TRF1 in response to 
ionizing DNA damage. Tankyrase 1 has been shown to regulate telomere length through 
its interaction with TRF1 [14, 15]. Overexpression of Tankyrase 1 induces poly(ADP-
ribosyl)ation of TRF1, resulting in dissociation of TRF1 from telomeres and allowing 
telomerase access to telomeres for telomere elongation [16]. The dissociated telomere-
unbound TRF1, by either activation of Tankyrase 1 or inhibition of CK2, is subsequently 
degraded via ubiquitin-mediated proteolysis by E3 ubiquitin ligases, such as Fbx4 [17-19] 
and RLIM [20]. Thus, various post-translational modifications of TRF1—including 
poly(ADP-ribosyl)ation by Tankyrase 1, phosphorylation by CK2, and ubiquitination by 
Fbx4 or RLIM—may modulate telomere length homeostasis by determining the level of 
TRF1 at telomeres. 
In this study, we identified a novel post-translational modification of TRF1, the 
conjugation of neural precursor cell expressed developmentally down-regulated 8 
(NEDD8) called neddylation. NEDD8 is one of the ubiquitin-like proteins, and its 
conjugation to target occurs similarly to ubiquitination [21]. NEDD8 is activated by an 
E1 enzyme (APPBP1/Uba3), transferred to an E2-conjugating enzyme (Ubc12/UBE2M 
or UBE2F), and subsequently targeted to substrates that are recognized by an E3 ligase 
[22]. The best-characterized substrates for neddylation are the cullin family members, 
which is the largest class of RING ubiquitin E3 ligases (CRLs). Neddylation activates the 
CRLs, implying that it is closely related to ubiquitination [23, 24]. Recently, Recently, 
non-CRL neddylation targets, including several transcription factors (e.g., p53 [25-27], 
E2F [28, 29], NFkB [30, 31]), and numerous signaling pathways (e.g., receptor Tyr 
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kinase signaling [32], apoptosis [33], DNA damage [34] and nucleolar stress signaling 
[35, 36]) have also been studied, indicating that NEDD8 might have additional biological 
functions [37]. Moreover, NEDD8 and the neddylation enzymes are overexpressed in 
human cancers, suggesting that excessive neddylation is involved in cancer development 
[38, 39]. MLN4924, a potent and selective inhibitor of Nedd8-activating enzyme (NAE), 
has been identified to suppress the growth of human tumors, and it disrupts CRL-
mediated protein turnover, leading to apoptosis in tumor cells [40]. To date, neddylation 
of TRF1 has not been reported. 
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3. Materials and Methods 
 
3.1 Cell culture and plasmids construction 
The human embryonic kidney cell line HEK293 were cultured in Dulbecco’s modified 
Eagle’s medium supplemented with 10% fetal bovine serum, 100units/ml penicillin, and 
100μg/ml streptomycin in 5% CO2 at 37°C. The expression vectors for Flag-TRF1, Myc-
SENP8, V5-NEDD8, HA-Ubiquitin were constructed by inserting the full-length cDNAs 
into pRK5-Flag, pRK5-Myc, pRK5-V5, and pRK5-HA (Stratagene), respectively. The 
expression vectors for EGFP-TRF1, EGFP-TRF1-NEDD8GG, EGFP-TRF1-
UbiquitinGG were constructed by inserting the full-length cDNAs into pEGFP-C2 
(Clontech). The expression vectors for His-TRF1 and GST-SENP8 were constructed by 
cloning the full-length and truncated fragments from the TRF1 or SENP8 cDNA into 
pET28a (Clontech) and pGEX-4T-2 (GE Healthcare), respectively. The GST fusion 
proteins were expressed and purified by using a glutathione-Sepharose 4B according to 
the manufacturer's instructions (Amersham Biosciences, Piscataway, NJ). The His fusion 
proteins were expressed and purified by using a Ni-NTA agarose according to the 
manufacturer's instructions (Invitrogen) 
 
3.2 GST Pull down, Immunoprecipitation, immunoblotting and antibodies 
The expression vectors were transiently transfected into HEK293 cells using 
Lipofectamine-PLUS reagent according to the manufacturer’s protocol (Invitrogen) for 
24 h followed by lysis. For GST pull down assay, lysates were precleared with 
glutathione-Sepharose 4B (Amersham Biosciences, Piscataway, NJ) and incubated with 
glutathione-Sepharose beads containing GST fusion proteins for 2 h at 4°C. For 
immunoprecipitation, lysates were preincubated with protein A-Sepharose (Amersham 
Biosciences, Piscataway, NJ) and incubated with anti-Flag (Sigma) or anti-Myc (Santa 
Cruz Biotechnology) antibodies precoupled with protein A-Sepharose beads for 2 h at 
4°C. Bound proteins were analyzed by SDS-PAGE, followed by immunoblotting. 
Immunoblotting were performed using anti-Flag (Sigma), anti-Myc (Santa Cruz 
Biotechnology), anti-V5 (Invitrogen), anti-NUB1 (Santa Cruz Biotechnology) and anti-
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tubulin (Santa Cruz Biotechnology) antibodies as specified. All the immunoblots are 
representatives of at least three experiments that demonstrated the similar results. 
 
3.3 In vitro Neddylation assay 
In vitro neddylation was performed using in vitro neddylation kit according to the 
manufacturer’s protocol (Enzo life science). For the in vitro TRF1 neddylation assay, 1ug 
of purified His-TRF1 was incubated with NEDD E1 (APPBP1-Uba3), E2 (UbcH12) and 
NEDD8 in a total reaction volume of 20ul (40mM Tris–HCl, pH 7.4, 5mM MgCl2, 2mM 
ATP and 2mM DTT). Samples were incubated at 37℃ for 1 h, and reactions were 
terminated with 2X non-reducing SDS-PAGE loading buffer (20mM Tris–HCl, pH 6.8, 
100mM DTT, 2% SDS, 20% glycerol and 0.016% Bromophenol blue) before western 
blotting. 
 
3.4 In vivo Neddylation and ubiquitination assay 
HEK293 cells transfected with Flag-TRF1, V5-Nedd8, Myc-SENP8 expression vectors 
were lysed in buffer (50 mM Tris, pH 7.5, 150 mM NaCl, 1% SDS, 10 mM NEM), 
followed by incubation with Benzonase (Sigma) at 37°C for 20 min. Lysates were 
subjected to immunoprecipitation with anti-Flag M2 affinity resins (Sigma), followed by 
immunoblotting with anti-V5 antibody to illuminate nedd8-conjugated TRF1. HEK293 
cells plated on 60-mm dishes were transfected with HA-TRF1, HA-TRF1 mutants 
(R425V or Myb), FN-TNKS1, FN-TNKS1-DM and His-Ub or His-NEDD8 experssion 
vectors, as indicated. Cells were harvested after 24 h, and 10% of the cell suspension was 
kept for input and lysed in 2X SDS sample buffer. The remaining cells were lysed in 6 ml 
of buffer I (6M guanidinium-HCl [pH 8.0], 0.1M Na2HPO4/ NaH2PO4, 0.01M Tris-Cl, 
10mM β-mercaptoethanol, and 5mM imidazole). 40ul of nickel-agarose beads were 
added, and lysates were rotated for O/N at 4℃. The beads were then sequentially washed 
for 5 min at room temperature in 1ml of buffer A (6M guanidinium-HCl [pH 8.0], 0.1M 
Na2HPO4/ NaH2PO4, 0.01M Tris-Cl, 10mM β-mercaptoethanol) and 1ml of buffer B (8M 
Urea [pH 8.0], 0.1M Na2HPO4/ NaH2PO4, 0.01M Tris-Cl, 10mM β-mercaptoethanol) and 
1ml of buffer C (8M Urea [pH 6.3], 0.1M Na2HPO4/ NaH2PO4, 0.01M Tris-Cl, 0.2% 
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Triton X-100, 10mM β-mercaptoethanol) and 1ml of buffer D (8M Urea [pH 6.3], 0.1M 
Na2HPO4/ NaH2PO4, 0.01M Tris-Cl, 0.1% Triton X-100, 10mM β-mercaptoethanol).  
 
3.5 Immunofluorescence and confocal microscopy  
Cells were grown on glass coverslips, fixed with 4% paraformaldehyde in phosphate-
buffered saline (PBS) for 10 min and permeabilized in 0.5% Triton X-100 in PBS for 20 
min. Cells were then blocked in PBS containing 5% bovine serum albumin and incubated 
with anti-Myc antibody (Santa Cruz Biotechnology, Santa Cruz, CA) overnight at 4°C. 
After washing with PBS, cells were incubated with Alexa Fluor 546 goat anti-mouse 
immunoglobulin (Molecular Probes). DNA was stained with 4,6-diamino-2-phenylindole 
(DAPI) (Vectashield; Vector Laboratories, Burlingame, CA). Immunofluorescence 
images were captured using a confocal laser-scanning microscope (Carl Zeiss LSM700, 
Carl Zeiss, Inc., Jena, Germany). 
 
3.6 Subcellular Fractionation 
Cells were collected by centrifugation at 3000 x g for 4 min at 4°C and suspended in 
400ul buffer A (10mM HEPES [pH 7.5], 10mM KCl, 1mM DTT, 1mM PMSF, 0.05% 
NP40). After incubation on ice for 10 min. Nuclei were pelleted at 3000 x g for 5 min, 
and the supernatant (cytoplasmic extracts) was centrifuged at 13,000 x g for 20min. 
Nuclei were washed with 1ml of buffer A twice and suspended in 100ul of buffer B (20 
mM HEPES [pH 7.5], 0.4M NaCl, 1mM DTT, 1mM PMSF. Nuclear extract was 
collected by centrifugation at 18,000 x g for 20 min. 
 
3.7 RNA interference 
The siRNA duplexes were transfected into HEK293 cells using Lipofectamine2000 
transfection reagent (Invitrogen). The siRNA target sequences specific for NEDD8 were 
5’-CATAATGAGGCATCATATA-3’. The scrambled sequence (5’-
AATCGCATAGCGTATGCCGTT-3’) was used as a negative control and did not 
correspond to any known gene in the data bases 
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4. Results 
 
4.1 TRF1 is target for NEDD8-conjugation system 
TRF1 is subject to extensive post-translational modifications that in turn contribute to 
the regulation of their stability, binding activity, and localization [11]. Several previous 
studies have shown the role of post-translational modifications in controlling TRF1, such 
as phosphorylation [12, 13], ubiquitylation [18, 20] and SUMOlyation [41] in telomere 
maintenance and DNA damage response. However, NEDD8 conjugation of TRF1 has not 
yet been determined. To investigate whether TRF1 can be conjugated with Nedd8, we 
first performed in vitro neddylation assays with purified His-TRF1, Nedd8, NAE (E1), 
and Ubc12 (E2); reacted them with or without the Mg-ATP condition; and analyzed them 
by immunoblotting using endogenous TRF1 antibody and NEDD8 antibody. The results 
showed that TRF1 migrated as high-molecular weight bands when the Nedd8, NAE (E1), 
Ubc12 (E2), and Mg-ATP were present in the reaction (Figure 1A). To verify whether 
TRF1 is neddylated in vivo, HEK293 cells were co-transfected with Flag-TRF1 and V5-
NEDD8 or V5-NEDD8GG mutant and subjected to immunoprecipitation with anti-Flag 
antibody followed by anti-V5 antibody. The NEDD8-conjugated TRF1 was readily 
detected in the immunoprecipitates; however, these bands disappeared in the presence of 
a Nedd8GG mutant, which abolishes the covalent conjugating ability of Nedd8 (Figure 
1B). These immunoprecipitated proteins were not recognized by the ubiquitin antibody. 
In addition, neddylated-TRF1 was eliminated by treatment with MLN4924, a potent and 
specific inhibitor of NAE (Figure 1C). Furthermore, we confirmed the in vivo neddylation 
of TRF1 using endogenous NEDD8 antibody to illuminate Nedd8-modified TRF1. 
Neddylated-TRF1 disappeared by MLN4924 treatment and by depletion of NEDD8 using 
NEDD8 siRNA (Figure 1D). Taken together, we found the novel post-translational 
modification of TRF1, which is NEDD8-conjugation, called neddylation. 
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Figure 1. TRF1 is target for NEDD8-conjugation. (A) Covalent neddylation of TRF1 
in vitro. Purified His-TRF1 proteins were incubated with Nedd8 and Nedd8-E1/E2. 
Reactions were performed as described in the Materials and Methods. Samples were 
analysed by western blotting with anti-TRF1 and anti-NEDD8 antibodies. (B) In vivo 
TRF1 neddylation assay. HEK293 cells were co-transfected with Flag-TRF1 with V5-
Nedd8 WT or GG and subjected to immunoprecipitation with anti-Flag antibody, 
followd by immunoblotting with anti-V5 antibody to detect Nedd8 conjugated TRF1. (C) 
TRF1 neddylation was significantly attenuated by the NAE inhibitor MLN4924. HEK293 
cells were co-transfected with Flag-TRF1 with V5-Nedd8 WT and treated with 
MLN4924 (1uM, 20h). Lysates subjected to immunoprecipitation with anti-Flag antibody, 
followd by immunoblotting with anti-V5 antibody. (D) In vivo TRF1 neddylation assay. 
HEK293 cells were transfected with Flag-TRF1 and treated with MLN4924 (1uM, 20h) 
and subjected to immunoprecipitation with anti-Flag antibody, followd by 
immunoblotting with anti-NEDD8 antibody to detect Nedd8 conjugated TRF1. (E) In 
vivo TRF1 neddylation assay. HEK293 cells were transfected with Flag-TRF1 and control 
siRNA or NEDD8 siRNA and subjected to immunoprecipitation with anti-Flag antibody, 
followd by immunoblotting with anti-NEDD8 antibody to detect Nedd8 conjugated TRF1. 
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4.2 Deneddylation enzyme NEDP1 abolishes covalent neddylation of TRF1 in vitro 
and in vivo 
To verify that these conjugations were neddylations, we performed in vitro neddylation 
assays and incubated the components with purified His-TRF1 and the GST-NEDP1, 
which is Nedd8-specific protease [42-44]. We found that NEDP1, which is Nedd8-
specific protease, efficiently removed these conjugation bands, suggesting that these 
conjugations are neddylations (Figure 2A). We next investigated the interaction of TRF1 
and NEDP1 using purified His-TRF1 and GST-NEDP1 by a GST pull-down assay. GST-
NEDP1, but not the control GST, precipitated His-TRF1, indicating that TRF1 associates 
with NEDP1 in vitro (Figure 2B). We further examined the effect of NEDP1 on the 
neddylation of TRF1 in vivo. HEK293 cells were co-transfected with Flag-TRF1, V5-
NEDD8, Myc-NEDP1, and Myc-NUB1 and subjected to immunoprecipitation with anti-
Flag antibody followed by anti-V5 antibody to detect Nedd8-modified TRF1. NUB1 has 
been shown to directly interact with NEDD8, and the characterized function of NUB1 
was recruiting NEDD8 and NEDD8 conjugates to the proteasome for degradation. 
Previously, we found NUB1 to be a TRF1-interacting protein; therefore, we also 
examined the neddylation of TRF1 by NUB1. We found that neddylated TRF1 was 
abolished by overexpression of NEDP1 and NUB1 (Figure 2C). Moreover, MG132 
treatment prevented the reduction caused by NUB1 but did not block the reduction caused 
by NEDP1, suggesting that NUB1 recruited the neddylated TRF1 to the proteasome for 
degradation and NEDP1 detached NEDD8 from TRF1 (Figure 2D). 
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Figure 2. Deneddylation enzyme NEDP1 abolished covalent neddylation of TRF1 in 
vitro and in vivo. (A) Purified His-TRF1 proteins were incubated with Nedd8, Nedd8-
E1/E2 and, with or without GST-NEDP1. Samples were analysed by western blotting 
with an anti-NEDD8 antibody. (B) NEDP1 specifically interacts with TRF1 in vitro and 
in vivo. GST, GST-NEDP1 were immobilized on glutathione-Sepharose and incubated 
with Purified His-TRF1. Bound proteins were detected by immunoblotting with anti-His 
antibody. (C) HEK293 cells were co-transfected with Flag-TRF1 and Myc-NEDP1 and 
subjected to immunoprecipitation with anti-Flag antibody, followed by immunoblotting 
with anti-Myc antibody. (D) HEK293 cells were co-transfected with Flag-TRF1, V5-
NEDD8 and Myc-NEDP1 and subjected to immunoprecipitation with anti-Flag antibody, 
followed by immunoblotting with anti-V5 antibody to detect Nedd8 conjugated TRF1. 
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4.3 NEDD8-conjugation stimulates cytoplasmic localization of TRF1 and reduces 
stability of TRF1 
Ubiquitin fusions have been demonstrated to mimic the mono-ubiquitination of many 
proteins. Although it remains unclear how accurately a C-terminal fusion represents the 
mono-ubiquitination of internal lysines, previous studies have shown that this alternative 
approach involves fusion of the required Ubl proteins, such as SUMO and NEDD8, to the 
C-terminus of the substrate protein to mimic the effects of mono-ubiquitination of a 
number of proteins, including p53 [26, 45], EGFR [32], DEDD [46]. Recently, the 
SUMOylation function of TRF1 was also reported by using the TRF1-SUMO fusion 
construct [41]. Mutation of the C-terminal glycines in the Ubl portion (GG) inhibits the 
formation of isopeptide bonds between Ubls and target lysines and thus prevents the use 
of the fusion proteins in this way. Based on previous studies, we generated TRF1-
NEDD8GG and TRF1-UbquitinGG fusion constructs analogous to the previous 
methods. HEK293 cells were transfected with GFP-TRF1, GFP-TRF1-NEDD8GG, and 
TRF1-UbGG fusion constructs, and the subcellular localization was analyzed. As shown 
in Figure 3A, GFP-TRF1 was predominantly localized to the nucleus, whereas 
NEDD8GG or UbGG fusion at the C-terminus of TRF1 led to the cytoplasmic 
localization of TRF1. To confirm the immunofluorescence results, we performed 
subcellular fractionation and analyzed the results by immunoblotting. The fractionation 
showed that GFP-TRF1 was detected mainly in the nucleus; however, the NEDD8- or 
ubiquitin-fused TRF1 was found in the cytoplasm and accumulated by MG132 treatment 
(Figure 3B, C), implying that mono-neddylation or mono-ubiquitination promotes the 
cytoplasmic localization of TRF1 and is subsequently degraded by the proteasome. We 
further confirmed that NEDD8 or Ub fusion affects the stability of TRF1. HEK293 cells 
were transfected with GFP-TRF1, GFP-TRF1-NEDD8GG, and TRF1-UbGG; treated 
with cycloheximide (100ug/ml) as indicated time to block new protein synthesis; and 
analyzed by immunoblotting with anti-GFP antibody. As shown in Figure 3D and 
graphically in Figure 3E, NEDD8, or ubiquitin fusion at the C-terminus of TRF1, reduced 
the half-life of TRF1 compared to the wild-type TRF1. 
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Figure 3. NEDD8-conjugation stimulates cytoplasmic localization of TRF1. (A) 
Schematic representation of the GFP-TRF1, GFP-TRF1-Nedd8GG and GFP-TRF1-
UbGG constructs used in this experiment. (B) MCF7 cells were transiently transfected 
with GFP-TRF1, GFP-TRF1-Nedd8GG and GFP-TRF1-UbGG as indicated and GFP-
fused proteins were monitored by confocal microscope. The nuclei were stained with 4,6-
diamidino-2-phenylindole (DAPI, blue).  (C) Cytoplasmic and nuclear fractions were 
analyzed by western blotting with anti-GFP antibodies. Lamin A/C and tubulin were used 
as nuclear and cytoplasmic markers, respectively. Bar graphs represent quantification of 
immunoblot images. (D) HEK293 cells were transfected with GFP-TRF1, GFP- 
Nedd8GG and GFP-TRF1-UbGG expression vectors and treated with 100μg/ml 
cycloheximide together with, or without, 10μM MG132 for the indicated times. (E) 
Lysates were analyzed by immunoblotting with anti-GFP and anti-tubulin antibodies and 
performed quantitation of immunoblot signals 
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4.4 MLN4924 treatment enhances stability of TRF1 and inhibits cytoplasmic export 
of TRF1 
Because MLN4924 efficiently abolished the NEDD8-conjugation of TRF1, we next 
examined its ability to regulate the level of TRF1. Interestingly, the level of TRF1 was 
increased by MLN4924 treatment (Figure 4A). In addition, the fractionation result 
showed that TRF1 levels greatly increased in the nucleus by MLN4924 treatment 
compared to the cytoplasm, and the cytoplasmic ratio per nucleus was significantly 
reduced compared to the DMSO treatment (Figure 4B, C). Taken together, inhibition of 
the NEDD8-conjugation system by MLN4924 treatment enhanced the stability of TRF1 
and inhibited the cytoplasmic export of TRF1. 
 
 
 
 
 
 
Figure 4. MLN4924 stablized the TRF1 levels. (A) HEK293 cells were transiently 
transfected with Flag-TRF1 and treated with 1uM of MLN4924 for 20hrs. Lysates were 
analyzed by immunoblotting with anti-Flag and anti-tubulin antibodies. (B) HEK293 
cells were transiently transfected with HA-TRF1 and treated with 1uM of MLN4924 for 
20hrs. Cytoplasmic and nuclear fractions were analyzed by western blotting with anti-HA 
antibodies. Lamin A/C and tubulin were used as nuclear and cytoplasmic markers, 
respectively. (C) Bar graphs represent quantification of immunoblot images. 
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4.5 Neddylation and ubiquitination of TRF1 is increased after release from telomere 
It has been reported that TRF1 is degraded by ubiquitin-mediated proteolysis after its 
release from telomeres [17]. Either NEDD8GG or UbGG fusion at the C-terminus of 
TRF1 causes a clear reduction in the half-life of TRF1 and promotes the cytoplasmic 
localization of TRF1. We further confirmed TRF1 neddylation using the R425V mutant 
and the Myb domain-deleted TRF1 construct. The R425V mutant was shown to disrupt 
the binding of TRF1 to the telomere [47], and the Myb domain of TRF1 was shown to be 
responsible for telomere binding [17, 18]. HEK293 cells were co-transfected with HA-
TRF1 or HA-TRF1 mutants (R425V or Myb) and His-NEDD8 or His-Ub expression 
vectors. Thereafter, cell lysates containing His Ub-modified or His NEDD8-modified 
proteins were precipitated under denaturing conditions by Ni-NTA pull-down, and the 
neddylated TRF1 and ubiquinated TRF1 were analyzed by immunoblotting using anti-
HA antibody. We found that neddylation of TRF1 is increased on the telomere unbound 
TRF1 mutant but does not occur on the Myb deletion mutant, and ubiquitination is also 
increased on TRF1 R425V mutants and abolished on Myb deletion mutants as reported 
previously, suggesting that NEDD8 conjugation of TRF1 is increased after release from 
telomere (Figure 5A, B). Furthermore, to examine whether the dissociation of TRF1 from 
telomere contributes to the neddylation of TRF1 in vivo, HEK293 cells were co-
transfected with HA-TRF1 and His-NEDD8, His-Ub and Flag-tankyrase1 (FN-TNKS1), 
or poly(ADP-ribose) polymerase (PARP) activity dead mutant of Flag-tankyrase1 (FN-
TNKS1 DM) expression vectors. Lysates were precipitated under denaturing conditions 
by Ni-NTA pull-down, and the neddylated-TRF1 and ubiquinated-TRF1 analyzed by 
immunoblotting using anti-HA antibody. It has been reported that the poly(ADP-
ribosyl)ation of TRF1 by overexpression of TNKS1 removes TRF1 from telomeres, 
resulting in TRF1 ubiquitination and degradation by the proteasome [14, 48]. We found 
that, like ubiquitination, overexpression of Tankyrase1 increased the neddylation of TRF1, 
whereas PARP-dead mutant of Tankyrase1 does not affect to the neddylation of TRF1 or 
ubiquitination of TRF1 (Figure 5C, D). Taken together, these results strongly indicate 
that neddylation of TRF1 is increased after release from telomere. 
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Figure 5. Neddylation and ubiquitination of TRF1 is increased after release from 
telomere. (A) HEK293 cells were co-transfected with His tagged NEDD8, HA-
TRF1(WT), HA-TRF1(R425V) and HA-TRF1(Myb) and performed Ni-NTA pull-down 
under denature condition followed by immunoblotting with anti-HA antibody. (B) 
HEK293 cells were transfected with His tagged Ubiquitin, HA-TRF1(WT), HA-
TRF1(R425V) and HA-TRF1Myb and performed Ni-NTA pull-down under denature 
condition followed by immunoblotting with anti-HA antibody. (C) HEK293 cells were 
co-transfected with His tagged NEDD8, HA-TRF1 and Flag-Tankylase1(WT) or Flag-
Tankylase1(DM) and performed Ni-NTA pull-down under denature condition followed 
by immunoblotting with anti-HA antibody. (D) HEK293 cells were co-transfected with 
His tagged Ubiquitin, HA-TRF1 and Flag-Tankylase1(WT) or Flag-Tankylase1(DM) and 
performed Ni-NTA pull-down under denature condition followed by immunoblotting with 
anti-HA antibody. 
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4.6 Neddylation and ubiquitination is linked for regulating the cellular abundance of 
TRF1 
Because TRF1 neddylation and ubiquitination occur in very similar ways, next we 
focus on possible linkage between neddylation and ubiquitination on TRF1. HEK293 
cells were co-transfected with V5-NEDD8 or HA-Ubiquitin, Flag-TRF1, Myc-Fbx4, 
Myc-NEDP1, and Myc-USP22 [49], which is TRF1-specific ubiquitin protease, as 
indicated. Cell lysates were immunoprecipitated with anti-Flag antibodies and the 
neddylated-TRF1 and ubiquinated-TRF1 analyzed by immunoblotting using anti-V5 
antibody and anti-HA antibody, respectively. Interestingly, deubiquitinase USP22 
abolished the ubiquitination but not neddylation of TRF1, and deneddylase NEDP1 
abolished the neddylation but not ubiquitination. Moreover, Fbx4 promotes the 
ubiquitination and the neddylation of TRF1, suggesting that neddylation may be linked 
with ubiquitination (Figure 6A, B). To further confirm whether the Fbx4 contributes to 
the neddylation of TRF1, HEK293 cells were co-transfected with His-NEDD8, HA-TRF1, 
Myc-Fbx4, Myc-SENP8, and Myc-UBE2M. UBE2M, which is NEDD8-specific E2 
enzyme, was used as a control. Lysates were precipitated under denaturing conditions by 
Ni-NTA pull-down and the neddylated-TRF1 analyzed using anti-HA antibody. We 
found that Fbx4 promotes the neddylation of TRF1 and that overexpression of NEDP1 
clearly abolished the neddylated TRF1 caused by Fbx4, suggesting that Fbx4 also 
stimulates the neddylation of TRF1 (Figure 6C). Additionally, we found that the 
ubiquitination of TRF1 is not affected by MLN4924 or depletion of NEDD8, and that 
NEDD8 overexpression significantly reduced the ubiquitination of TRF1 (Figure 6D). 
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4.7 Identification of NEDD8-conjugation site on TRF1 
To examine the exclusive function of TRF1 neddylation, we tried to identify the 
NEDD8-conjugation site on TRF1. We found that neddylation of TRF1 is increased on 
the telomere unbound TRF1 mutant but does not occur on the Myb deletion mutant 
(Figure 5A). There are eight lysine residues on the Myb domain of TRF1. To examine 
which lysine residue(s) could be neddylated, we mutated each lysine into arginine. 
However, none of these mutations could abolish the TRF1 neddylation (Figure 7A). To 
further validate that Myb domain lysine residues are neddylated, we mutated all eight 
lysine residues into arginine sequentially. However, even though all eight lysine residues 
were mutated into arginine, TRF1 could still be neddylated (Figure 7B), suggesting that 
Myb domain deletion might affect conformation of TRF1, resulting in different 
consequences between domain study and mutagenesis study. Further study is required to 
identify the NEDD8-conjugation sites for TRF1. 
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Figure 6. Possible linkage between neddylation and ubiquitination of TRF1 (A) In 
vivo ubiquitination assay. HEK293 cells were co-transfected with Flag-TRF1, HA-
Ubiquitin and Myc-Fbx4 or Myc-NEDP1 or Myc-USP22 and subjected to 
immunoprecipitation with anti-Flag antibody, followed by immunoblotting with anti-HA 
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antibody to detect ubiquitinated TRF1 (B) In vivo neddylation assay. HEK293 cells were 
co-transfected with Flag-TRF1, V5-NEDD8 and Myc-Fbx4 or Myc-NEDP1 or Myc-
USP22 and subjected to immunoprecipitation with anti-Flag antibody, followed by 
immunoblotting with anti-V5 antibody and anti-HA antibody to detect Nedd8 conjugated 
TRF1 and ubiquitinated TRF1, respectively. (C) In vivo neddylation assay under 
denaturation condition. HEK293 cells were co-transfected with HA-TRF1, His-NEDD8, 
Myc-Fbx4,Myc-NEDP1, and Myc-UBE2M. and lysates were precipitated by Ni-NTA 
pull-down and the neddylated-TRF1 analyzed using anti-HA antibody (D) In vivo 
ubiquitination assay under denaturation condition. HEK293 cells were co-transfected 
with HA-TRF1, His-Ub, Myc-NEDP1, V5-NEDD8, V5NEDD8GG, and 1uM od 
MLN4924 for 4hrs as indicated. Lysates were precipitated by Ni-NTA pull-down and the 
neddylated-TRF1 analyzed using anti-HA antibody 
 
 
 
 
Figure 7. Identification of NEDD8-conjugation site on TRF1 (A) In vivo neddylation 
assay under denaturation condition. HEK293 cells were co-transfected with various Flag-
tagged point mutants of TRF1 and, His NEDD8. Lysates were precipitated by Ni-NTA 
pull-down and the neddylated-TRF1 analyzed using anti-Flag antibody (B) In vivo 
neddylation assay. HEK293 cells were co-transfected with various Flag-tagged multiple 
lysine(K)-mutants of TRF1, V5-NEDD8 subjected to immunoprecipitation with anti-Flag 
antibody, followed by immunoblotting with anti-V5 antibody to detect neddylated TRF1. 
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5. Discussion 
 
TRF1 directly binds to telomeric DNA and plays crucial roles in the maintenance of 
telomere length and structure. The post-translational modification of TRF1 is important 
for modulating telomere length homeostasis by regulating the cellular abundance of TRF1. 
Recent biochemical studies have revealed the existence of numerous modifying enzymes, 
which contribute to the regulation of stability, binding activity, and localization of TRF1 
[11]. Phosphorylation of TRF1 is mainly involved in the telomeric binding activity and 
stability, modulated by many different kinases such as AKT, ATM, CDK1, CK2, and Plk1. 
Overexpression of AKT led to an increase in the level of TRF1 and a decrease in telomere 
length [50] and ATM negatively regulates TRF1 binding to telomeric DNA, which in turn 
promotes telomerase-dependent telomere lengthening [51]. Plk1-mediated 
phosphorylation and CK2-mediated phosphorylation promotes interaction between TRF1 
and telomeric DNA [12, 13]. MMS21-mediated SUMOylation has been reported to 
facilitate the TRF1 association with telomeric DNA needed for telomere recombination in 
ALT cells [52]. Poly(ADP-ribosyl) ation of TRF1 by Tankyrase1 removes TRF1 from 
telomeric DNA, after which dissociated TRF1 is ubiquitinated by Fbx4 and RLIM to 
promote ubiquitin-mediated proteolysis [19, 20]. These post-translational modifications 
are very close to each other for controlling the TRF1, and they play crucial roles in the 
maintenance of telomere length and structure. 
Here, we identified the novel post-translational modification of TRF1 (i.e., 
neddylation). Although cullin family proteins are the best-validated target for neddylation, 
recent studies have reported that several non-cullin proteins are also neddylated and, in 
turn, regulate the diverse cellular processes [37]. In this paper, it is found for the first time 
that TRF1 is a target for NEDD8-conjugation in vitro and in vivo and the treatment of 
MLN4924, which is an NAE inhibitor [39], efficiently reduces the neddylation of TRF1. 
NEDP1 is a Cys protease that selectively binds to NEDD8 resulting in removal of 
NEDD8 from neddylated substrates [42, 44]. We also identified that NEDP1 directly 
interacts with TRF1 in vitro and clearly abolished the neddylation of TRF1 in vitro and in 
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vivo. To date, NEDD8-conjugation of TRF1 has not been reported; therefore, we further 
confirmed the function of neddylation on TRF1.  
NEDD8-conjugation is similar to ubiquitination. To examine the biological function of 
- -fused TRF1 constructs for 
mimicking the mono-neddylated or mono-ubiquitinated TRF1, based on the previous 
studies [26, 41]. Interestingly, we found that the expression of these C-terminal fusion 
proteins in the cytoplasm and accumulated by MG132 treatment, implying that 
neddylation led to cytoplasmic localization of TRF1 and was degraded by proteasome. 
Moreover, the stability of TRF1 was also decreased by fusion of NEDD8 or ubiquitin, 
which suggests that mono-neddylation as well as mono-ubiquitination are involved in the 
stability and subcellular localization of TRF1. These results remain unclear because the 
C-terminal fusion is not quite accurate compared with actual neddylation that occurs in 
internal lysine on TRF1. Additionally, we found that the TRF1 levels are greatly 
increased by MLN4924 treatment, especially in nuclear fraction, indicating that the 
inhibition of neddylation stabilizes the level of TRF1 and prevents the cytosolic 
localization of TRF1. 
As NEDD8 and the neddylation enzymes are overexpressed in human cancers, 
NEDD8-mediated protein turnover is a novel and effective anticancer strategy [39]. 
Earlier studies have shown that the activity of CRLs is directly regulated by modification 
with NEDD8, resulting in controlling the ubiquitination and subsequent proteasomal 
degradation of numerous CRL target proteins [53, 54]. Inhibition of NAE by MLN4924 
led to diverse cellular dysfunctions, such as DNA re-replication and damage that, in turn, 
fails to repair, leading to apoptosis or senescence [55, 56]. MLN4924 also inhibits the 
neddylation of non-cullin substrates; however, the biological consequences have not been 
studied. In this study, we found that neddylation of TRF1 is inhibited and expression level 
dramatically increased by MLN4924 treatment. The cellular abundance of TRF1 was 
directly involved in telomere length regulation, suggesting that neddylation plays crucial 
roles in regulation of TRF1. 
Previous reports have shown that the TRF1 is degraded by ubiquitin-mediated 
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proteolysis after release from telomeres by tankyrase1-mediated poly(ADP-ribosyl)ation 
[17]. We found that neddylation of TRF1 was also increased by tankyrase1 
overexpression, similar to ubiquitination. Ubiquitination of TRF1 is mediated by the Fbx4, 
which is a subunit of the Skp1-Cul1/Rbx1-F-box protein) ubiquitin E3 ligases. 
Unexpectedly, we found that Fbx4 also promotes the TRF1 neddylation, suggesting that 
Fbx4, as a TRF1-specific adaptor, stimulates both ubiquitination and neddylation of TRF1. 
Several reports have shown that neddylation is linked with ubiquitination. However, 
knowledge of a link between the two effects on TRF1 remains unclear. Thus, further work 
is required to assess whether TRF1 neddylation has a physiological significance and a 
biological function.  
The dynamic regulation of TRF1 at telomeres by post-translational modifications and 
their interacting proteins, such as TIN2, Tankyrase1, and Fbx4, plays an important role in 
telomere homeostasis maintenance [11]. Dissociation of TRF1 from telomeres by 
Tankyrase1 allows the telomerase access to the chromosome ends for telomere extension; 
therefore, unbound TRF1 is subsequently degraded by ubiquitin-mediated degradation 
[17]. On the other hand, TIN2 protects TRF1 from ubiquitination and recycles the TRF1 
back to the telomeres through deubiquitination. Therefore, TRF1 is required for efficient 
telomere DNA replication [57]. The present findings suggest that novel post-translational 
modification of TRF1, called neddylation for controlling the stability and subcellular 
localization, provides a potential mechanism for telomere maintenance. 
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Figure. 8. Model for regulation of TRF1 by Neddylation 
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국문 요약 
 
샤프론 단백질에 의한 텔로머라아제의 핵 이동과 
텔로미어 결합단백질인 TRF1의 조절에 관한 연구 
 
연세대학교 대학원  
융합오믹스 의생명과학과  
정유영 
 
텔로미어는 TTAGGG라는 단순한 반복 DNA배열로 구성되는 진핵생물 염색체의 
말단영역으로, 6종류의 말단소체 결합단백질로 둘러싸여있으며 염색체 말단을 
DNA 손상 반응 단백질의 인식으로부터 피하기 위해 T-loop을 형성한다. 진핵
세포는 선형 유전체를 가지고 있는데, 각 세포 주기마다 말단의 뉴클레오티드
를 잃어버리게 되면서 점점 짧아져 불안정하게 된다. 따라서 진핵세포에서는 
염색체 말단에 이러한 반복 DNA배열 구조를 통해 말단 복제문제를 해결하고 
있다. 텔로미어의 길이가 일정 수준보다 짧아지게되면, 세포 노화 상태 또
는 세포사멸이 일어나게 된다. 인간의 체세포는 텔로미어의 연장을 위한 메커
니즘이 없어서 여러 번의 세포분열 후 더 이상 증식을 할 수 없게되지만 암세
포는 무한한 세포 성장을 위해 텔로미어 길이를 늘리게 되는데, 이는 말단소
체복원효소(telomerase)에 의해서 일어나게 된다.  따라서 텔로미어와 말단소
체복원효소에 대한 연구는 인간의 노화와 암에 대한 기작 및 치료를 위한 좋
은 연구대상이다. 본 논문에서는 말단소체복원효소의 핵으로의 이동과 활성조
절에 대한 연구와, 텔로미어 결합단백질 중에서 TRF1의 안정성 조절과 전사후 
변형(post-translational modification)에 대한 연구에 대해 기술하였다. 
우리는 말단소체복원효소와 상호작용하는 새로운 단백질인 FKBP52를 발견하
였다.  FKBP52는 스테로이드 호르몬 수용기 단백질을 핵으로 이동시키는 과정
에 관여하는 것으로 잘 알려져 있는데, 이를 기반으로 FKBP52 단백질이 말단
소체복원효소의 핵 이동에도 연관이 있을것이라 가설을 세우고 연구를 진행하
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였다. 말단소체복원효소의 조립 및 활성 조절에는 다양한 샤프론 단백질들(예, 
Hsp90, p23)이 중요하게 작용하는데, FKBP52는 이 샤프론중에 하나인 hsp90와 
직접 결합하고 또한 세포질 내의 단백질이동에 관여하는 dynein/dynactin 
moter 단백질과도 직접적으로 결합하고 있다. 이 연구를 통해 우리는 FKBP52 
단백질이 다른 샤프론 단백질들과 함께 말단소체복원효소의 세포질에서부터 
핵으로의 이동하는 과정에 중요하게 작용하는 것을 발견하였고, 또한 말단소
체복원효소의 활성조절에도 중요하게 작용하는것을 확인하였다. 
또한 우리는 말단소체 결합단백질인 TRF1과 상호 작용하는 새로운 단백질로
써 NUB1을 발견하였고, NUB1이 직접적으로 TRF1과 단백질 분해효소
(proteasome)와의 연결에 관여함으로써 TRF1의 안정성 조절에 작용하고 있음
을 확인하였다. NUB1 단백질은 전사후 변형기작중의 하나인 NEDD8 단백질의 
접합과정을 저해하는 것으로 잘 알려져 있는데, 이를 바탕으로 우리는 TRF1에 
NEDD8이 접합되는지 확인하였고, Neddylation이라는 TRF1의 새로운 전사후 변
형 메커니즘을 확인하였다. 또한 우리는 TRF1에 NEDD8이 접합 되었을 때, 
TRF1 단백질의 세포내 위치가 세포질로 이동하는 것을 확인하였고, 안정성이 
감소하는 것 또한 확인하였다. 그리고 세포내 NEDD8 접합 시스템을 저해하였
을 때, TRF1 단백질의 안정성이 매우 증가하는 것을 확인하였다. 또한 TRF1의 
neddylation이 텔로미어 DNA로부터 떨어졌을 때 촉진되는 것을 확인하였는데, 
이는 이전연구인 TRF1의 ubiquitination과 유사한 양상으로 나타남을 확인하
였다. TRF1의 neddylation과 ubiquitination의 상호작용에 대해서는 추가적인 
연구가 필요하다. 본 연구를 통해 우리는 말단소체복원효소의 핵이동에 관여
하는 단백질인 FKBP52와, 텔로미어 결합단백질인 TRF1의 세포내 안정성 조절
및 새로운 전사후 변형기작의 발견으로 텔로미어의 유지 및 통제에 대한 새로
운 메커니즘을 제안하고자 한다. 
 
 
중심단어: 텔로미어(telomere), 말단소체복원효소(telomerase), FKBP52, 
Hsp90, dynein/dynactin, TRF1, NUB1, 단백질 분해효소, 전사후 변형(post-
translational modification) 
